var title_f21_61_22480="Positive patch test reactions";
var content_f21_61_22480=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F76954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F76954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 615px\">",
"   <div class=\"ttl\">",
"    Positive patch test reactions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 595px; height: 166px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    From left to right: +++ reaction; ++ reaction (note the microvesicles); + reaction; +/- reaction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Panel 1 reproduced with permission from: DermNet NZ. For more information, visit",
"     <a href=\"file://dermnetnz.org\" target=\"_blank\">",
"      file://dermnetnz.org",
"     </a>",
"     . Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22480=[""].join("\n");
var outline_f21_61_22480=null;
var title_f21_61_22481="Pleural lymphoma II CT";
var content_f21_61_22481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pleural lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pleural lymphoma involving the left pleural space. CT scan shows a large left pleural effusion producing diaphragmatic inversion. Anterior left parietal pleural tumor nodules are visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22481=[""].join("\n");
var outline_f21_61_22481=null;
var title_f21_61_22482="Radical vaginectomy";
var content_f21_61_22482=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radical vaginectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 280px; height: 515px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The assistant guides the application of the Zeppelin forceps to the paravaginal tissues from below, thereby protecting the vagina from inclusion in the clamp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22482=[""].join("\n");
var outline_f21_61_22482=null;
var title_f21_61_22483="Hepatitis A";
var content_f21_61_22483=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Hepatitis A (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/61/22483/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22483/contributors\" id=\"au4027\">",
"       Catherine P Cheney, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/61/22483/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22483/contributors\" id=\"se6409\">",
"       Sanjiv Chopra, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/61/22483/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22483/contributors\" id=\"de1811\">",
"       Elinor L Baron, MD, DTMH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?21/61/22483?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HEPATITIS A OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Hepatitis is a common form of liver injury that simply means \"inflammation of the liver\" (the suffix \"itis\" means inflammation and \"hepa\" means liver). Hepatitis A is a specific type of hepatitis that is caused by a virus.",
"    </p>",
"    <p>",
"     Hepatitis A virus (HAV) infection occurs worldwide. The number of people who become infected with HAV in the United States has declined substantially since a vaccine became available; the vaccine is routinely recommended for all infants and any adult who is at high risk of becoming infected. In 2005, 1.5 people per 100,000 were infected with HAV; this is the lowest infection rate ever recorded [",
"     <a class=\"abstract\" href=\"UTD.htm?21/61/22483/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     However, the infection rate is much higher in developing countries. Among travelers to developing countries, about three in every 1,000 travelers staying in luxury hotels acquire hepatitis A every month, and about 20 in every 1,000 travelers who eat or drink in poor hygienic conditions acquire hepatitis A every month.",
"    </p>",
"    <p>",
"     This topic review discusses how hepatitis A is spread, the signs and symptoms of HAV infection, how it is diagnosed and treated, and how it can be prevented. Other types of hepatitis are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      \"Patient information: Hepatitis B (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=see_link\">",
"      \"Patient information: Hepatitis C (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HOW DID I BECOME INFECTED WITH HEPATITIS A?",
"     </span>",
"    </p>",
"    <p>",
"     The hepatitis A virus is carried in the stool of infected people. The most common way for the virus to be spread is when an infected person does not wash their hands after using the bathroom and then touches food, a surface, or another person's mouth.",
"    </p>",
"    <p>",
"     Hepatitis A virus is more common in areas that lack adequate sanitation or have poor hygiene practices. The majority of people who acquire the illness have had personal contact with an infected person.",
"    </p>",
"    <p>",
"     Community outbreaks have occurred as a result of drinking contaminated well water or eating contaminated food. In one report, hepatitis A virus was detected in well water six months after the initial contamination [",
"     <a class=\"abstract\" href=\"UTD.htm?21/61/22483/abstract/2\">",
"      2",
"     </a>",
"     ]. Hepatitis A virus can be acquired from contaminated food, usually raw shellfish that is harvested from contaminated water. Several outbreaks occurred as a result of eating contaminated green onions, which were imported from Mexico [",
"     <a class=\"abstract\" href=\"UTD.htm?21/61/22483/abstract/3\">",
"      3",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HEPATITIS A SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Hepatitis A virus usually causes a sudden and short-lived illness. The severity of symptoms depends upon the person's age; in children, there may be few or no symptoms. In adults, infection usually causes a mild flu-like illness. Less commonly in adults, hepatitis A virus infection causes liver failure, which can lead to death.",
"    </p>",
"    <p>",
"     The time from infection to the development of symptoms is approximately 30 days, with a range of 15 to 49 days. Initial symptoms usually include fatigue, feeling run down, nausea, vomiting, lack of appetite, fever (temperature greater than 100.4&ordm; F or 38&ordm; C), and pain under the ribs on the right side of the abdomen (where the liver is located) (",
"     <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"      figure 1",
"     </a>",
"     ). As the illness progresses, other signs and symptoms develop, including dark-colored urine, light colored stools, yellow colored skin or whites of the eyes (jaundice), and itchy skin.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      HEPATITIS A DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     A person is diagnosed with hepatitis A virus based upon their signs or symptoms, a physical examination, and blood testing. The blood test becomes positive about 5 days before symptoms appear and remains positive for about six months after infection.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      HEPATITIS A TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     There is no cure for hepatitis A virus, although most people recover with supportive treatments at home, including rest. The amount of time needed to recover depends upon the individual; in general, the person should not return to work or school until the fever and jaundice have resolved and the appetite has returned.",
"    </p>",
"    <p>",
"     During the recovery period, it is important to avoid drinking alcohol and taking certain prescription and over-the-counter medications (eg,",
"     <span class=\"nowrap\">",
"      acetaminophen/Tylenol&reg;),",
"     </span>",
"     which can injure the liver. People who drink alcohol on a regular basis (eg, seven to 14 drinks per week) should never take acetaminophen, even if they have not been infected with hepatitis, due to the risk of liver injury.",
"    </p>",
"    <p>",
"     Less commonly, people infected with hepatitis A virus require treatment in a hospital to monitor the liver function, manage complications such as bleeding, provide adequate nutrition, and in rare cases, perform liver transplantation.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      HEPATITIS A COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Most people feel better within three months of becoming infected with hepatitis A virus, and almost everyone completely recovers within six months. About 15 percent of people infected with hepatitis A virus will have prolonged or relapsing symptoms during the first six to nine months after being infected.",
"    </p>",
"    <p>",
"     The most serious complication of hepatitis A virus infection is death. This occurs rarely, but is more likely in adults with chronic liver infections such as hepatitis C and those who are elderly. Children die as a result of hepatitis A virus in less than 0.1 percent of cases. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=see_link\">",
"      \"Patient information: Hepatitis C (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Unlike with other forms of hepatitis, people with hepatitis A do not develop chronic liver disease as a result of their infection. Once a person is infected with hepatitis A virus, it is not possible to become infected again.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      HEPATITIS A PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     Hepatitis A virus infection is preventable with several strategies, discussed below. Hand washing is one of the most effective strategies for reducing transmission since the virus can live on the fingers for up to four hours.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Hand hygiene",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hand washing is an essential and effective way to prevent the spread of infection. Hands should ideally be wet with water and plain or antimicrobial soap, and rubbed together for 15 to 30 seconds. Special attention should be paid to the fingernails, between the fingers, and the wrists. Hands should be rinsed thoroughly, and dried with a single use towel.",
"    </p>",
"    <p>",
"     It is not clear if alcohol-based hand rubs are effective against hepatitis A virus. For this reason, food handlers, day care providers, travelers, and anyone else who is at risk of transmitting or becoming infected with HAV is advised to wash their hands with soap and water when possible. Alcohol-based hand rubs are a reasonable alternative if a sink is not available.",
"    </p>",
"    <p>",
"     Hands should be cleaned after changing a diaper or touching any soiled item. They should also be washed before and after preparing food and eating, after going to the bathroom, and after handling garbage or dirty laundry.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Safe food preparation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Taking precautions when preparing foods can reduce the risk of becoming ill. The following precautions have been recommended by the Food Safety and Inspection Services (",
"     <a class=\"external\" href=\"file://www.fsis.usda.gov\">",
"      www.fsis.usda.gov",
"     </a>",
"     ) and the Centers for Disease Control and Prevention.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Do not drink raw (unpasteurized) milk or foods that contain unpasteurized milk.",
"      </li>",
"      <li>",
"       Wash raw fruits and vegetables thoroughly before eating.",
"      </li>",
"      <li>",
"       Keep the refrigerator temperature at 40&ordm;F (4.4&ordm;C) or lower; the freezer at 0&ordm;F (-17.8&ordm;C) or lower.",
"      </li>",
"      <li>",
"       Use precooked, perishable, or ready-to-eat food as soon as possible.",
"      </li>",
"      <li>",
"       Keep raw meat, fish, and poultry separate from other food.",
"      </li>",
"      <li>",
"       Wash hands, knives, and cutting boards after handling uncooked food, including produce and raw meat, fish, or poultry.",
"      </li>",
"      <li>",
"       Thoroughly cook raw food from animal sources to a safe internal temperature: ground beef 160&ordm;F (71&ordm;C); chicken 170&ordm;F (77&ordm;C); turkey 180&ordm;F (82&ordm;C); pork 160&ordm;F (71&ordm;C).",
"      </li>",
"      <li>",
"       Cook chicken eggs thoroughly, until the yolk is firm.",
"      </li>",
"      <li>",
"       Refrigerate foods promptly. Never leave cooked foods at room temperature for more than two hours (one hour if the room temperature is above",
"       <span class=\"nowrap\">",
"        90&ordm;F/32&ordm;C).",
"       </span>",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     People who are preparing to travel to areas where HAV infections commonly occur should take precautions when eating and drinking to avoid becoming ill. These precautions are discussed in detail in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=see_link&amp;anchor=H5#H5\">",
"      \"Patient information: General travel advice (Beyond the Basics)\", section on 'Food and water precautions'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Hepatitis A vaccination",
"     </span>",
"     &nbsp;&mdash;&nbsp;Two vaccines are available to prevent infection with hepatitis A virus; the vaccines are called VAQTA and HAVRIX. Both are equally effective, and protect nearly 100 percent of people who receive two doses for a lifetime. The initial dose of either vaccine usually provides adequate short-term protection, and the subsequent doses provide long-term protection. Thus, if a person does not have time to receive both doses before traveling, it is worth administering one dose and then completing the second six to 12 months later (",
"     <a class=\"graphic graphic_table graphicRef78137 \" href=\"UTD.htm?34/4/34891\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     The most common side effect of the hepatitis A virus vaccine is brief redness or discomfort at the injection site.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       VAQTA is given in two doses, with the second dose given six to 18 months after the first. This vaccine was temporarily recalled in the fall of 2001 because some prefilled syringes did not contain the proper amount of antigen to produce a reliable amount of antibody; this problem was subsequently corrected. People who were previously vaccinated against hepatitis A should contact their healthcare provider to determine which vaccine was given, and if revaccination is needed.",
"      </li>",
"      <li>",
"       HAVRIX is given in two doses, with the second dose given six to 12 months after the first.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If the second dose is not given within the recommended time frame, it can be given without restarting the series. A vaccination series started with one brand of vaccine may be completed with the same or other brand of hepatitis A vaccine.",
"    </p>",
"    <p>",
"     Hepatitis A vaccine is recommended for all children between 12 and 23 months of age. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      \"Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The hepatitis A virus vaccine is recommended for all",
"     <strong>",
"      at-risk adults",
"     </strong>",
"     , including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Travelers to countries where hepatitis A virus is common; the vaccine can be given at any time before traveling.",
"      </li>",
"      <li>",
"       Injection and non-injection illegal drug users",
"      </li>",
"      <li>",
"       Men who have sex with men",
"      </li>",
"      <li>",
"       People with chronic liver disease",
"      </li>",
"      <li>",
"       Adults with blood clotting factor disorders",
"      </li>",
"      <li>",
"       Adults who are at risk for infection at work, including day care center staff, personnel in healthcare facilities (eg, nursing homes), and food handlers.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     There is no information about the safety of the hepatitis A virus in pregnancy. However, the risk to the developing baby is likely to be low. Women who are at risk for hepatitis A and are pregnant should discuss the risks and benefits of the hepatitis A virus vaccine with their obstetrical healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Immune globulin",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who are at risk for hepatitis A but who are allergic to components of the hepatitis A vaccine or who prefer not to receive the vaccine should consider taking a dose of immune globulin. Immune globulin is an injection that provides temporary protection against hepatitis A and reduces the risk of infection by more than 90 percent. However, the hepatitis A vaccine is preferred to immune globulin in most cases because it provides long-lasting protection and because immune globulin is not always available.",
"    </p>",
"    <p>",
"     Immune globulin is given in a single injection shortly before travel. A single dose provides protection for about three months. Individuals who plan to travel for more than 5 months in areas where hepatitis A is endemic should have an additional dose of immune globulin (",
"     <a class=\"graphic graphic_table graphicRef78137 \" href=\"UTD.htm?34/4/34891\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Older adults and people with a weakened immune system, chronic liver disease, or other underlying medical problem who plan to travel",
"     <strong>",
"      within two weeks",
"     </strong>",
"     should be given a dose of hepatitis A vaccine in addition to a dose of immune globulin. The second dose of the HepA vaccine should be given 6 to 12 months later. Immune globulin is not required for healthy travelers who are immunized with the hepatitis A vaccine.",
"    </p>",
"    <p>",
"     The timing of immune globulin relative to certain other vaccines is important. Immune globulin should be given at least two weeks after the MMR (measles, mumps, rubella) vaccine. Conversely, the MMR vaccine should be given at least three months after immune globulin. The timing of immune globulin relative to other vaccines, including the yellow fever and poliovirus vaccine, is not important.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      TREATMENT AFTER EXPOSURE TO HEPATITIS A",
"     </span>",
"    </p>",
"    <p>",
"     If a person is exposed to hepatitis A and has not previously received the hepatitis A vaccine, a dose of the vaccine or immune globulin should be given as soon as possible;",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       One dose of the vaccine is preferred for people aged 12 months to 40 years.",
"      </li>",
"      <li>",
"       One dose of immune globulin is preferred for people older than 40 years.",
"      </li>",
"      <li>",
"       Children who are less than 12 months and people with a weakened immune system, chronic liver disease, and those who cannot tolerate the vaccine should be given one dose of immune globulin.",
"      </li>",
"      <li>",
"       Post-exposure treatment is not necessary for people who have previously been vaccinated with two doses of the hepatitis A vaccine.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A description of the groups who require post-exposure treatment is provided in the table (",
"     <a class=\"graphic graphic_table graphicRef66335 \" href=\"UTD.htm?30/25/31132\">",
"      table 2",
"     </a>",
"     ):",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Close personal contact",
"     </span>",
"     &nbsp;&mdash;&nbsp;Anyone who lives with, has had sexual contact with, or shared intravenous drugs with a person who is diagnosed with hepatitis A should have post-exposure treatment. The vaccine or immune globulin is suggested for anyone else who has had ongoing, frequent close personal contact (eg, a nanny) with an infected person.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Child care centers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hepatitis A vaccine or immune globulin is recommended for unvaccinated staff and children in a day care center in some situations. A detailed explanation of the recommendation is provided in the table (",
"     <a class=\"graphic graphic_table graphicRef66335 \" href=\"UTD.htm?30/25/31132\">",
"      table 2",
"     </a>",
"     ). The infected child or staff member should not return to day care until the fever and jaundice have resolved and the appetite has returned.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Common-source exposure",
"     </span>",
"     &nbsp;&mdash;&nbsp;If a person who handles food in a restaurant setting becomes infected with hepatitis A, all of his or her co-workers should be treated for hepatitis A (",
"     <a class=\"graphic graphic_table graphicRef66335 \" href=\"UTD.htm?30/25/31132\">",
"      table 2",
"     </a>",
"     ). The infected food handler should not return to work until the fever and jaundice have resolved and the appetite has returned.",
"    </p>",
"    <p>",
"     It is not usually necessary to treat people who have eaten at the restaurant, unless certain criteria are met; these are described in the table (",
"     <a class=\"graphic graphic_table graphicRef66335 \" href=\"UTD.htm?30/25/31132\">",
"      table 2",
"     </a>",
"     ). However, adults and children who regularly eat at a school or work cafeteria that employs an infected food handler may be encouraged to have post-exposure treatment; a healthcare provider should be consulted to determine if post-exposure treatment is needed in these situations.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Schools and work settings",
"     </span>",
"     &nbsp;&mdash;&nbsp;If a single child in elementary or secondary school becomes infected with hepatitis A, it is not usually necessary to treat his or her classmates if the infection was likely acquired outside the school (",
"     <a class=\"graphic graphic_table graphicRef66335 \" href=\"UTD.htm?30/25/31132\">",
"      table 2",
"     </a>",
"     ). Similarly, if a single adult becomes infected, his or her fellow employees do not usually need to be treated.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29278568\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29278583\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/46/41698?source=see_link\">",
"      Patient information: Hepatitis A (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/22/4451?source=see_link\">",
"      Patient information: Latest medicines for hepatitis C (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/45/1746?source=see_link\">",
"      Patient information: Vaccines when you have hepatitis C (The Basics)",
"     </a>",
"    </p>",
"    <p>",
"     <br/>",
"     <strong>",
"     </strong>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29278629\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=see_link\">",
"      Patient information: Hepatitis C (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=see_link\">",
"      Patient information: General travel advice (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29278646\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32980?source=see_link\">",
"      Atypical manifestations of hepatitis A virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7591?source=see_link\">",
"      Overview of hepatitis A virus infection in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC) (available in Spanish)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 311-3435",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/hepatitisa.html\">",
"      www.nlm.nih.gov/medlineplus/hepatitisa.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases (available in Spanish)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://digestive.niddk.nih.gov/ddiseases/pubs/hepa_ez/\">",
"      file://digestive.niddk.nih.gov/ddiseases/pubs/hepa_ez/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Liver Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.liverfoundation.org/\">",
"      www.liverfoundation.org",
"     </a>",
"     )",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 24, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?21/61/22483?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22483/abstract/1\">",
"      Wasley A, Miller JT, Finelli L, Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis--United States, 2005. MMWR Surveill Summ 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22483/abstract/2\">",
"      De Serres G, Cromeans TL, Levesque B, et al. Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J Infect Dis 1999; 179:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22483/abstract/3\">",
"      Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005; 353:890.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f21_61_22483=[""].join("\n");
var outline_f21_61_22483=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HEPATITIS A OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HOW DID I BECOME INFECTED WITH HEPATITIS A?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HEPATITIS A SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           HEPATITIS A DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           HEPATITIS A TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           HEPATITIS A COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           HEPATITIS A PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           TREATMENT AFTER EXPOSURE TO HEPATITIS A",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\" title=\"figure 1\">",
"           Abdomen anatomy adult PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?34/4/34891\" title=\"table 1\">",
"           HAV vaccine recs PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?30/25/31132\" title=\"table 2\">",
"           HAV post exp treatment PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22484="Mechanisms of glomerular hyperfiltration in diabetes mellitus";
var content_f21_61_22484=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of glomerular hyperfiltration in diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22484/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22484/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22484/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22484/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22484/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22484/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22484/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/61/22484/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 25 to 50 percent elevation in the glomerular filtration rate (GFR) is seen early in the course in up to one-half of patients with type 1 diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/1\">",
"     1",
"    </a>",
"    ], an abnormality that is exaggerated after ingestion of a protein load [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/2\">",
"     2",
"    </a>",
"    ]. Glomerular hypertrophy and increased renal size typically accompany the rise in GFR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperfiltration also occurs early in the course of type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In an original report of 110 newly diagnosed patients with type 2 diabetes mellitus, for example, the GFR was above 140",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    in 16 percent and more than two standard deviations above the mean of a control population in 45 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/3\">",
"     3",
"    </a>",
"    ]. The prevalence of hyperfiltration may be lower in the era of more aggressive glucose control. A later study of 93 newly diagnosed patients, for example, found that 17 percent had a GFR that was more than two standard deviations above the mean of a control population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of hyperfiltration and the course of the GFR in type 2 diabetes mellitus was evaluated in more detail in a study of 194 Pima Indians who had GFR measured using iothalamate clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/4\">",
"     4",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 31 patients with a normal glucose tolerance test, the mean GFR was 123",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"     </li>",
"     <li>",
"      In 29 patients with impaired glucose tolerance, the mean GFR was 135",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"     </li>",
"     <li>",
"      In 30 patients with newly diagnosed type 2 disease, the mean GFR was 143",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"     </li>",
"     <li>",
"      In 70 patients with overt diabetes for more than five years and either normal albumin excretion or microalbuminuria, the mean GFR was 153",
"      <span class=\"nowrap\">",
"       mL/min;",
"      </span>",
"      in 34 similar patients with overt proteinuria, the mean GFR was 124",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After four years of follow-up, the GFR rose 14 percent in patients with impaired glucose tolerance, 18 percent in newly diagnosed patients, was stable in those with microalbuminuria, and fell 35 percent in those with overt proteinuria. The rate of fall in GFR in the last group was 0.93",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per month, a rate similar to that seen in type 2 diabetes with overt proteinuria.",
"   </p>",
"   <p>",
"    These hemodynamic and structural changes may be important clinically, because intraglomerular hypertension (which is responsible for part of the rise in GFR) and glomerular hypertrophy (which increases shear stress on the glomerular capillary wall) may play an important role in the development and progression of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link\">",
"     \"Overview of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Measurement of GFR is usually required to detect hyperfiltration because estimation equations, such as the MDRD Study equation, usually underestimate the true GFR when it is normal or above normal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=see_link\">",
"     \"Assessment of kidney function\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=see_link&amp;anchor=H6#H6\">",
"     \"Assessment of kidney function\", section on 'Estimation of GFR'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in experimental animals indicate that dilatation of the afferent (precapillary) glomerular arteriole plays an important role in the hyperfiltration response, by raising both the intraglomerular pressure and renal blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/1\">",
"     1",
"    </a>",
"    ]. Why these hemodynamic changes occur is not well understood, but the following factors appear to contribute.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;A role for hormones is suggested by the ability of a chronic infusion of a somatostatin analogue (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    ) to partially reverse both the early hyperfiltration and the increase in renal size in type 1 diabetic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/7\">",
"     7",
"    </a>",
"    ]. In this study, glucose control and plasma glucagon and growth hormone levels were unchanged. There was, however, a fall in the plasma concentration of insulin-like growth factor I (IGF-1), which is produced in part within the kidney.",
"   </p>",
"   <p>",
"    Although the pathogenetic role of IGF-1 is unproven, it is of interest that infusion of this hormone in normal subjects can replicate the findings seen in diabetics &mdash; renal vasodilatation and an elevation in GFR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/8\">",
"     8",
"    </a>",
"    ]. Similar hemodynamic changes plus renal hypertrophy can be induced by IGF-I in experimental animals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to IGF and other hormones, atrial natriuretic peptide had been postulated to contribute to hyperfiltration, but this is unproven [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Volume expansion due to increased sodium reabsorption may trigger its secretion, which can result in dilation of the afferent arteriole. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Increased sodium reabsorption and tubuloglomerular feedback'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Sex hormones may affect the degree of glomerular hyperfiltration. In one study, females had a reduction in renal plasma flow and renal blood flow, and decreased renal vascular resistance in response to hyperglycemia, but no change was detected in males [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/12\">",
"     12",
"    </a>",
"    ]. With ACE inhibition, both genders had a reduction in arterial pressure, but only females exhibited reduction in glomerular filtration rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Sorbitol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other factors directly related to hyperglycemia also may be important, including the intracellular accumulation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    and the formation of glycosylated proteins. The enzyme aldose reductase converts intracellular glucose to sorbitol, which then accumulates within the cells. Studies in hyperfiltering humans with type 1 diabetes have shown that the chronic administration of an aldose reductase inhibitor (tolrestat) lowers the GFR toward normal. In one study of patients who also had microalbuminuria, for example, the GFR fell from 156 to 124",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    and albumin excretion fell from 197 to 158",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    after six months of tolrestat [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/13\">",
"     13",
"    </a>",
"    ]. The possible efficacy of this regimen to prevent diabetic nephropathy remains to be determined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/44/13000?source=see_link\">",
"     \"Aldose reductase inhibitors in the prevention of diabetic complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Glycation products",
"    </span>",
"    &nbsp;&mdash;&nbsp;In chronic hyperglycemia, some of the excess circulating glucose combines with free amino acids on circulating or tissue proteins. This nonenzymatic process initially forms reversible early glycation products and later irreversible advanced glycation end products, which may accumulate in tissues and contribute to the renal and microvascular complications of diabetes (",
"    <a class=\"graphic graphic_figure graphicRef80716 \" href=\"UTD.htm?22/4/22606\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link\">",
"     \"Overview of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In normal rats, the infusion of early glycation products to achieve plasma concentrations similar to that seen in diabetic rats can induce the increases in renal plasma flow, GFR, and intraglomerular pressure typical of untreated diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/15\">",
"     15",
"    </a>",
"    ]. The applicability of this observation to humans is at present unproven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Increased sodium reabsorption and tubuloglomerular feedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced tubular sodium reabsorption, due to augmented sodium-glucose cotransport, leading to extracellular fluid volume expansion may be an additional factor contributing to the rise in GFR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. Hyperinsulinemia (due to subcutaneous administration) and mild hyperglycemia can also stimulate sodium reabsorption, the latter via increased sodium-glucose cotransport in the proximal tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The rise in proximal reabsorption initially decreases distal fluid delivery which, by activating the tubuloglomerular feedback mechanism in the macula densa, can then raise the GFR via dilatation of the afferent arteriole [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22484/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The hyperfiltration in this setting is appropriate from a renal viewpoint since it counteracts the effect of enhanced proximal reabsorption, thereby returning distal sodium and water delivery toward normal and preventing excess fluid retention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21341632\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elevations in the glomerular filtration rate (GFR) are seen early in the course in many patients with diabetes mellitus. Glomerular hypertrophy and increased renal size typically accompany the rise in GFR. Intraglomerular hypertension and glomerular hypertrophy may play an important role in the development and progression of diabetic nephropathy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link\">",
"       \"Overview of diabetic nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dilatation of the afferent (precapillary) glomerular arteriole plays an important role in hyperfiltration. Factors that may contribute to afferent arteriole dilatation include insulin-like growth factor I, atrial natriuretic peptide, sex hormones, intracellular",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      , early glycation products and enhanced tubular sodium reabsorption in the proximal tubule. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/1\">",
"      Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/2\">",
"      Tuttle KR, Bruton JL, Perusek MC, et al. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/3\">",
"      Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992; 41:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/4\">",
"      Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996; 335:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/5\">",
"      Jin Y, Moriya T, Tanaka K, et al. Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2006; 71:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/6\">",
"      Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetes Complications 1994; 8:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/7\">",
"      Serri O, Beauregard H, Brazeau P, et al. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/8\">",
"      Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993; 43:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/9\">",
"      Hirschberg R, Kopple JD. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol 1992; 2:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/10\">",
"      Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes. J Diabetes Complications 1995; 9:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/11\">",
"      Vervoort G, Veldman B, Berden JH, et al. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 2005; 35:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/12\">",
"      Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/13\">",
"      Passariello N, Sepe J, Marrazzo G, et al. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care 1993; 16:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/14\">",
"      Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int 1996; 49:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/15\">",
"      Sabbatini M, Sansone G, Uccello F, et al. Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 1992; 42:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/16\">",
"      Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 2003; 14:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/17\">",
"      Hannedouche TP, Delgado AG, Gnionsahe DA, et al. Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 1990; 37:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22484/abstract/18\">",
"      Vallon V, Richter K, Blantz RC, et al. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999; 10:2569.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3064 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-257308528F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22484=[""].join("\n");
var outline_f21_61_22484=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21341632\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hormones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Sorbitol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Glycation products",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Increased sodium reabsorption and tubuloglomerular feedback",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21341632\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3064\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3064|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/4/22606\" title=\"figure 1\">",
"      Glycosylation of proteins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/44/13000?source=related_link\">",
"      Aldose reductase inhibitors in the prevention of diabetic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=related_link\">",
"      Assessment of kidney function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=related_link\">",
"      Overview of diabetic nephropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22485="Formoterol and mometasone: Pediatric drug information";
var content_f21_61_22485=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Formoterol and mometasone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2774?source=see_link\">",
"    see \"Formoterol and mometasone: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?3/4/3142?source=see_link\">",
"    see \"Formoterol and mometasone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F10379527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10356502\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dulera&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F12817177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zenhale&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F13388052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenal Corticosteroid",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenergic Agonist Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Beta",
"       <sub>",
"        2",
"       </sub>",
"       -Adrenergic Agonist",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Bronchodilator",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Corticosteroid, Inhalant (Oral)",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Glucocorticoid",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F13388060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2774?source=see_link\">",
"      see \"Formoterol and mometasone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral inhalation:",
"     <b>",
"      Asthma, maintenance treatment:",
"     </b>",
"     Initial dose based on previous corticosteroid dosage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children and Adolescents &ge;12 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Previous medium dose inhaled corticosteroids: Mometasone 100 mcg/formoterol 5 mcg (Dulera&reg; 100 mcg/5 mcg): 2 inhalations twice daily; maximum daily dose: 4 inhalations/day. In patients not adequately controlled on the lower combination dose following 2 weeks of therapy, consider the higher dose combination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Previous high dose inhaled corticosteroids: Mometasone 200 mcg/formoterol 5 mcg (Dulera&reg; 200 mcg/5 mcg): 2 inhalations twice daily; maximum daily dose: 4 inhalations/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Dulera&reg; 100 mcg/5 mcg, Dulera&reg; 200 mcg/5 mcg: 2 inhalations twice daily. Do not exceed 4 inhalations/day. In patients not adequately controlled on the lower combination dose following 2 weeks of therapy, consider the higher dose combination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Mometasone systemic exposure appears to increase with increasing extent of impairment; however, there is no dosage adjustment recommended in the manufacturer labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10379678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, for oral inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulera&reg;: Mometasone furoate 100 mcg and formoterol fumarate dihydrate  5 mcg per inhalation (8.8 g) [60 metered actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulera&reg;: Mometasone furoate 100 mcg and formoterol fumarate dihydrate  5 mcg per inhalation (13 g) [120 metered actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulera&reg;: Mometasone furoate 200 mcg and formoterol fumarate dihydrate  5 mcg per inhalation (8.8 g) [60 metered actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulera&reg;: Mometasone furoate 200 mcg and formoterol fumarate dihydrate  5 mcg per inhalation (13 g) [120 metered actuations]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F10379532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10379528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at  file://www.spfiles.com/mgdulera.pdf; must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13388061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prior to first use, inhaler must be primed by releasing 4 test sprays into the air; shake well before each spray.  Inhaler must be reprimed if not used for &gt;5 days. Shake well before each use. Rinse mouth after each use. Discard inhaler after the labeled number of inhalations have been used.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F13388057\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Do not puncture, incinerate, or store near heat or open flame; exposure to temperatures above 120&deg;F may cause bursting. Discard inhaler after the labeled number of inhalations have been used.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13388053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maintenance treatment of asthma (FDA approved in ages &ge;12 years and adults );",
"     <b>",
"      NOT",
"     </b>",
"     indicated for the relief of acute bronchospasm",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F10379568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Also see individual agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Dysphonia, nasopharyngitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Anaphylactoid reactions, angina pectoris, angioedema, asthma aggravation, atrial fibrillation, blood pressure increased, hyperglycemia, hypertension, hypokalemia, hypotension, oral candidiasis, pruritus, QT prolongation, rash, tachyarrhythmia, ventricular extrasystoles",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13388054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mometasone, formoterol, adrenergic amines, or any component; treatment of acute asthma or status asthmaticus",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F13388137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with cardiovascular disease (arrhythmia or hypertension or HF), seizure disorders, diabetes, hypokalemia, liver dysfunction, thyrotoxicosis, or others who are sensitive to the effects of sympathomimetic amines. Suppression of HPA function, suppression of linear growth (ie, reduction of growth velocity), reduced bone mineral density or hypercorticism (Cushing's syndrome) may occur; titrate to lowest effective dose. Reduction in growth velocity [mean: 1 cm/year (range: 0.3-1.8 cm)] may occur when corticosteroids are administered to pediatric patients, even at recommended doses via inhaled route; related to dose and duration of exposure; monitor growth. Use with extreme caution in patients with respiratory tuberculosis, untreated systemic infections, or ocular herpes simplex. Rare cases of increased IOP, glaucoma, or cataracts have been reported with inhaled corticosteroids, including mometasone. Immediate hypersensitivity reactions (urticaria, angioedema, rash, bronchospasm) have been reported.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use with caution with potent inhibitors of cytochrome P450 isoenzyme CYP3A4 (eg, ritonavir, ketoconazole); may increase mometasone serum concentrations and result in systemic corticosteroid effects.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13388055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists (LABAs), such as formoterol, increase the risk of asthma-related deaths",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; mometasone and formoterol should only be used in patients not adequately controlled on a long-term asthma control medication (ie, inhaled corticosteroid) or whose disease severity requires initiation of two maintenance therapies. In a large clinical trial, LABA (salmeterol) use was associated with an increase in asthma-related deaths  compared to placebo (when added to usual asthma therapy); risk is considered a class effect among all LABAs. Data are not available to determine if the addition of an inhaled corticosteroid lessens this increased risk of death associated with LABA use. Assess patients at regular intervals once asthma control is maintained on combination therapy to determine if step down therapy is appropriate (without loss of asthma control), and the patient can be maintained on an inhaled corticosteroid only. LABAs are not appropriate in patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids. LABAs may increase the risk of asthma-related hospitalization in pediatric and adolescent patients",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Mometasone and formoterol  should not be used to relieve acute asthmatic symptoms or rapidly deteriorating or potentially life-threatening episodes of asthma; acute episodes should be treated with short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist. Routine use of inhaled, short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists should be discontinued  prior to initiation of mometasone and formoterol. Mometasone and formoterol should not be used more frequently than recommended (twice daily), at higher doses, nor with any additional long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic agonist; adverse cardiovascular effects (possibly fatal) have been reported with excessive beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic overstimulation. Paroxysmal bronchospasm (which can be fatal) has been reported with this and other inhaled beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist agents. If this occurs, discontinue treatment; symptoms of laryngeal spasm, irritation, or swelling, such as stridor and choking, have been reported in patients receiving mometasone and formoterol; if this occurs, discontinue treatment.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Fatalities have occurred due to adrenal insufficiency in asthmatic patients during and after switching from systemic corticosteroids to inhaled steroids; several months may be required for full recovery of hypothalamic-pituitary-adrenal (HPA) function; patients receiving higher doses of systemic corticosteroids (eg, adults receiving &ge;20 mg of prednisone per day) may be at greater risk; during this period of HPA suppression, inhaled steroids do not provide the systemic glucocorticoid or mineralocorticoid activity needed to treat patients requiring stress doses (ie, patients with major stress such as trauma, surgery, infections, or other conditions associated with severe electrolyte loss). When used at high doses, HPA suppression may occur; use with inhaled or systemic corticosteroids (even alternate day dosing) may increase risk of HPA suppression. Acute adrenal insufficiency may occur with abrupt withdrawal after long-term use or with stress; withdrawal or discontinuation of corticosteroids should be done carefully; patients with HPA axis suppression may require doses of systemic glucocorticosteroids prior to, during, and after unusual stress (eg, surgery). Switching patients from systemic corticosteroids to inhaled steroids may unmask allergic conditions (eg, rhinitis, conjunctivitis, eczema, arthritis, eosinophilic conditions) previously suppressed by the systemic steroid. Immunosuppression may occur; patients may be more susceptible to infections; avoid exposure to chickenpox and measles.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      C. albicans",
"     </i>",
"     infections of the mouth and pharynx may occur with orally inhaled corticosteroid use, mostly mild to moderate; interruption of therapy may be necessary at times while antifungal therapy is employed; advise patients to rinse mouth after use. Hypersensitivity reactions with angioedema and swelling of the lips, tongue, and pharynx have been reported rarely.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F10379572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F10486859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphotericin B: Corticosteroids (Orally Inhaled) may enhance the hypokalemic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Corticosteroids (Orally Inhaled) may diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Corticosteroids (Orally Inhaled). Management: Monitor for signs and symptoms of adrenal suppression if inhaled budesonide or mometasone are coadministered with a strong CYP3A4 inhibitor.  Avoid combining inhaled fluticasone with any strong CYP3A4 inhibitor.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Corticosteroids (Orally Inhaled) may enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Corticosteroids (Orally Inhaled) may enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F10379538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10379539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13388062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pulmonary function tests, check mucous membranes for signs of fungal infection; monitor growth in pediatric patients; serum glucose and serum potassium",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13388058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Formoterol is a long-acting selective beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic receptor agonist. It relaxes bronchial smooth muscle by selective action on beta",
"     <sub>",
"      2",
"     </sub>",
"     receptors with little effect on heart rate. Mometasone is a corticosteroid which controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes/fibroblasts, and reverses capillary permeability and lysosomal stabilization at the cellular level to prevent or control inflammation.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13388059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F13388063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/4/3142?source=see_link\">",
"      see \"Formoterol and mometasone: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not intended for treatment of acute asthma attacks. Full response to this medication may not be seen for 1-2 weeks. Use regularly. Do not stop treatment, even if feeling better. Notify physician if condition being treated persists or worsens; do not decrease dose or discontinue without physician approval. Avoid exposure to chicken pox or measles; if exposed, seek medical advice without delay. Rinse mouth after each use; report sore mouth or mouth lesions, persistent headache, or nosebleeds to physician; carefully read and follow the patient instructions for use leaflet that accompanies the product. When mometasone and formoterol is initiated, discontinue regular use of short-acting beta agonist and utilize the shorter-acting agent for symptomatic acute episodes only.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      National Asthma Education and Prevention Program (NAEPP), \"Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma,&rdquo;",
"      <i>",
"       Clinical Practice Guidelines",
"      </i>",
"      , National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm",
"      </a>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17070 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.80.101-F770B2E4D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22485=[""].join("\n");
var outline_f21_61_22485=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379527\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10356502\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817177\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388052\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388060\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379678\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379532\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379528\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388061\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388057\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388053\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379568\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388054\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388137\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388055\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379572\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10486859\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379538\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10379539\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388062\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388058\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388059\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13388063\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/17070\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/17070|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2774?source=related_link\">",
"      Formoterol and mometasone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/4/3142?source=related_link\">",
"      Formoterol and mometasone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22486="Multifocal atrial tach tutorial";
var content_f21_61_22486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1046px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Multifocal atrial tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 279px; height: 119px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multifocal atrial tachycardia is similar to a wandering atrial pacemaker, except that the heart rate is rapid (greater than 100 beats per minute). There is great variability of the P wave morphology and axis, the PR intervals, and the cycle lengths of the QRS complexes. The QRS complexes are unchanged and are similar to sinus rhythm since ventricular activation is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22486=[""].join("\n");
var outline_f21_61_22486=null;
var title_f21_61_22487="Use of pulmonary function testing in the diagnosis of asthma";
var content_f21_61_22487=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of pulmonary function testing in the diagnosis of asthma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Charles G Irvin, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Peter J Barnes, DM, DSc, FRCP, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22487/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/61/22487/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of asthma is characterized by a pattern of lung dysfunction that includes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airflow limitation that reverses with bronchodilator administration.",
"     </li>",
"     <li>",
"      Variable airflow limitation, which can be either circadian or episodic in nature.",
"     </li>",
"     <li>",
"      Airways hyperresponsiveness, which is an excessive decrease in airflow in response to specific stimuli or \"triggers\" (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link\">",
"       \"Risk factors for asthma\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unlike other pulmonary diseases, asthma cannot be identified by a definitive pathologic picture or one diagnostic test. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    .) Rather, the diagnosis of asthma is based upon an appropriate clinical history and characteristic findings from a series of pulmonary function tests [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. These tests most often include different measures of airflow, bronchodilator responses, lung volumes, and the diffusing capacity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEASURES OF AIRFLOW LIMITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The detection of airflow limitation in the patient with asthma can be accomplished with a variety of techniques. The most common are the measurement of peak expiratory flow rate (PEFR), forced expiratory volume in one second (FEV1), and the flow-volume relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. It is important to realize that these endpoints are not necessarily equivalent because of the complex physiology of the lung and the clinical state of the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Peak expiratory flow rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peak expiratory flow rate (PEFR) is measured during a maximally forceful and rapid exhalation that immediately follows a maximal inhalation. The utility of PEFR to detect the presence of airflow limitation is not particularly good, since the variability of PEFR among individuals is very large (+30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, PEFR is a useful method of monitoring changes or trends in the patient's lung function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/2,3,6-10\">",
"     2,3,6-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several shortcomings of measurement of PEFR, the most serious of which is its significant dependence on effort [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/2,3,8\">",
"     2,3,8",
"    </a>",
"    ]. Accordingly, it is important that patients are taught and observed, and proper technique should be reinforced at each clinic visit [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A zone scheme based on a traffic light paradigm is used for categorizing results of PEFR measurements and asthma action plans:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Red is defined as less than 50 percent of the predicted or personal best values.",
"     </li>",
"     <li>",
"      Yellow is defined as 50 to 80 percent of the predicted or personal best values.",
"     </li>",
"     <li>",
"      Green is defined as greater than 80 percent of the predicted or personal best values.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These categories can then be used to monitor asthma status and guide alteration of medication regimens (",
"    <a class=\"graphic graphic_figure graphicRef79373 \" href=\"UTD.htm?14/21/14686\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/3,6,7\">",
"     3,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Self-determined PEFR has become an important endpoint utilized in asthma management schemes for the following reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It can be measured both in the laboratory or office and at home by the patient.",
"     </li>",
"     <li>",
"      Peak flow meters are inexpensive and easy to use.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient should perform the PEFR maneuver three or more times and record the best value in a diary. Progressive falls in PEFR over several days may indicate worsening of asthma, which may or may not be accompanied by changes in clinical status (",
"    <a class=\"graphic graphic_figure graphicRef79373 \" href=\"UTD.htm?14/21/14686\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/53/854?source=see_link\">",
"     \"Peak expiratory flow rate monitoring in asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several situations in which PEFR can be misleading:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PEFR can fall during a course of systemic glucocorticoids, if the respiratory muscles weaken.",
"     </li>",
"     <li>",
"      PEFR may not adequately reflect airflow limitation in some patients (see below). Much like using a blood gas to \"calibrate\" the pulse oximeter, it is important initially to correlate PEFR values with a more definitive and less effort-dependent measures of airflow limitation, ie, spirometry and flow-volume loops.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Spirometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007 National Asthma Education and Prevention Program (NAEPP) guidelines recommend the use of spirometry to evaluate and monitor asthma in practices that are regularly caring for patients with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/6\">",
"     6",
"    </a>",
"    ]. Spirometry allows measurement of lung volumes during the execution of a forced expiratory maneuver (ie, a maximal inhalation to total lung capacity followed by a maximal exhalation) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5607?source=see_link\">",
"     \"Office spirometry\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although numerous indices can be derived from the spirogram, three are most important:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The forced vital capacity (FVC), which is the total volume of air exhaled.",
"     </li>",
"     <li>",
"      The FEV1, which is the volume exhaled in the first second of expiration.",
"     </li>",
"     <li>",
"      The ratio of FEV1 to FVC, or",
"      <span class=\"nowrap\">",
"       FEV1/FVC",
"      </span>",
"      ratio [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/2,4\">",
"       2,4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Measurements of FEV1, FVC, and",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio are reproducible, with coefficients of variation usually at 5 percent or less [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio has also been shown in numerous studies to be sensitive to the presence of airflow limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. FEV1 usually falls more than the FVC if the airways narrow, whereas the fall in FEV1 tracks the fall in FVC if the airways close [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Flow-volume relationships",
"    </span>",
"    &nbsp;&mdash;&nbsp;The flow-volume relationship or loop is obtained by plotting flow against volume during the FVC (forced expiratory) maneuver. This measurement yields useful additional information beyond that obtained with measurement of FEV1 and FVC, specifically by providing rapidly recognizable patterns that permit the clinician to differentiate bronchial asthma from the airflow limitation due to other causes, such as vocal cord dysfunction or a fixed obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25878?source=see_link\">",
"     \"Flow-volume loops\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The flow-volume loops in the figure demonstrate some of the patterns that can be encountered (",
"    <a class=\"graphic graphic_figure graphicRef80042 \" href=\"UTD.htm?11/30/11759\">",
"     figure 2",
"    </a>",
"    ). As an example, the reductions in maximal respiratory flow shown in the lower three panels often accompany clinical symptoms of dyspnea and wheeze. However, the cause of airflow limitation in these situations is central airway narrowing rather than asthma. Such patients will not respond to asthma therapy, since inflammation or bronchospasm are not likely the causes of the airflow limitation. Patterns suggestive of restrictive or mixed processes should alert the clinician to consider other disease processes, such as allergic bronchopulmonary aspergillosis.",
"   </p>",
"   <p>",
"    Once it has been determined that the patient has airflow limitation, the next step is to assess whether the airflow limitation is reversible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Bronchodilator responses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airflow limitation from asthma should usually demonstrate some degree of reversibility following acute treatment with a beta-agonist. The currently recommended criteria for a significant response to a bronchodilator in adults are that either FVC or FEV1 should increase by 12 percent and by at least 200 mL, although complete consensus on this is lacking [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In preparation for assessing bronchodilator reversibility, short-acting inhaled bronchodilators (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    , salbutamol,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/37/33360?source=see_link\">",
"     ipratropium",
"    </a>",
"    ) should not be used for four hours prior to testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/8\">",
"     8",
"    </a>",
"    ]. Long-acting beta-agonist bronchodilators (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/63/34806?source=see_link\">",
"     salmeterol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=see_link\">",
"     formoterol",
"    </a>",
"    ) are omitted for 12 hours prior to testing, and the long-acting anticholinergic agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/34/27173?source=see_link\">",
"     tiotropium",
"    </a>",
"    is omitted for 24 hours. Most laboratories use two metered-dose inhaler inhalations of a rapidly acting beta-agonist, such as albuterol, with an appropriate delay (10 to 20 minutes) to allow the beta-agonist to work. However, a case can also be made for the administration of a beta-agonist by nebulizer until side effects, eg, heart rate over 150, are observed. This maximal approach eliminates issues of aerosol distribution, inadequate dose-response, and patient technique [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with baseline airflow limitation, failure to improve following bronchodilator administration suggests an alternate diagnosis (eg, COPD) or airways inflammation that requires additional therapy (eg, glucocorticoids).",
"   </p>",
"   <p>",
"    In patients with normal spirometry at baseline, a bronchodilator response with an increase in FEV1 of more than 8 percent may suggest underlying airflow limitation, since the patient may have once had higher than predicted lung function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has also been suggested that clinicians measure other parameters of airflow obstruction in addition to spirometry, such as specific airway conductance (SGaw) obtained with a plethysmograph. This approach increases the likelihood of observing airflow reversibility. As an example, one study of 100 patients with clinically suspected reversible airway obstruction reported that spirometry detected reversible obstruction in 82 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/10\">",
"     10",
"    </a>",
"    ]. Further examination using body plethysmography revealed that 15 of the remaining 18 patients also responded to bronchodilators. If a patient fails to show an improvement in FEV1 with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    treatment and a clinical response appears to occur, body plethysmography can be used to document this change.",
"   </p>",
"   <p>",
"    Another response that can be observed after bronchodilator use is a change in lung volumes for a given flow, ie, an isovolume shift in the flow volume curve without a change in FEV1 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2,10\">",
"     1,2,10",
"    </a>",
"    ]. This results from opening of lung units previously \"trapped\" at high lung volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/11\">",
"     11",
"    </a>",
"    ]. However, despite these units being open, their resistances remain high, and they do not contribute to the FEV1 except to the extent that FVC falls. The figure shows common patterns of flow volume loop response following bronchodilator administration (",
"    <a class=\"graphic graphic_figure graphicRef75013 \" href=\"UTD.htm?23/16/23822\">",
"     figure 3",
"    </a>",
"    ). It is important to realize that not all of these responses result in changes in PEFR, FVC, or even FEV1. In such cases, other measurements are needed, such as SGaw or lung volumes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bronchoprovocation challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient with mild or no airflow limitation may not show reversal after bronchodilator administration. In such cases, a bronchial challenge with inhaled",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    would be indicated to demonstrate reversible airflow obstruction. A discussion of methacholine inhalation challenge and other types of bronchoprovocation is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LUNG VOLUMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of lung volumes and capacities can be important in the evaluation of patients with asthma for a number of reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lung volumes change over time and with treatment due to several different mechanisms. Understanding the nature of this change yields insights into the pathophysiologic mechanisms of this disease [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2,11\">",
"       1,2,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lung volumes provide indirect information about the elastic recoil of the chest wall and lung, with the latter being an important determinant of driving pressure for maximum expiratory airflow [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lung volume is an important determinant of airways caliber through the tethering effect of parenchymal attachments.",
"     </li>",
"     <li>",
"      Measurement of lung volumes can be quite useful in excluding other causes of dyspnea or periodic airflow limitation due to restrictive processes, which can masquerade clinically as asthma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Only three of the measurements of lung volumes or capacities provide useful information about the pathophysiology of asthma (",
"    <a class=\"graphic graphic_figure graphicRef55440 \" href=\"UTD.htm?38/28/39373\">",
"     figure 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Total lung capacity (TLC)",
"     </li>",
"     <li>",
"      Functional residual capacity (FRC)",
"     </li>",
"     <li>",
"      Residual volume (RV)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Spirometry measures several volumes and capacities, but these volumes (inspiratory reserve volume, tidal volume, expiratory reserve volume) and capacities (inspiratory capacity) are not generally helpful in asthma management [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Measurement of functional residual capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of RV and TLC requires that FRC first be measured, which is accomplished with either dilution of an inert gas or by applying Boyle's law to thoracic gas with measurements made in a whole body plethysmograph.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To determine FRC with inert gas dilution, the patient respires pure oxygen while breathing on a circuit; the fall in expired nitrogen over ensuing breaths is measured (nitrogen washout). Alternatively, the patient may breathe into a gas reservoir of known volume containing a low concentration of helium. As the lung equilibrates with the known volume of inert gas, the volume diluted (FRC) can be calculated. Either technique measures only those parts of the lung which communicate with the main airway.",
"     </li>",
"     <li>",
"      To determine FRC with the body plethysmograph, the patient enters a chamber about the size of a phone booth. While the patient is breathing quietly, the airway is occluded at FRC with a shutter, and changes in mouth pressure and volume in the plethysmograph are recorded as the patient continues ventilatory efforts. Boyle's law is then used to determine FRC.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lung volumes determined by plethysmography in patients with asthma are preferable to those determined by dilution, because the presence of trapped gas can lead to falsely lowered volumes determined by dilution and an erroneous conclusion that a mixed disease process is present [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, an evaluation of patient effort is required to avoid problems in interpreting changes in RV and TLC (high and low, respectively) which are due to poor inspiratory and expiratory efforts (",
"    <a class=\"graphic graphic_figure graphicRef64766 \" href=\"UTD.htm?21/52/22350\">",
"     figure 5",
"    </a>",
"    ). This is usually accomplished by inspecting the data for reproducibility and noting technician comments concerning patient effort and cooperation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Residual volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;RV is the most consistently abnormal of all the lung volumes in asthmatic patients, and it is the last to return to normal following treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/14\">",
"     14",
"    </a>",
"    ]. However, measurement of RV is highly variable, and a value greater than approximately 150 percent of predicted is required before one interprets an abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/5\">",
"     5",
"    </a>",
"    ]. If not due to poor expiratory effort, a high RV is interpreted as abnormal closure of airways, which can be confirmed by observing a fall in RV following bronchodilator therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Functional residual capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The FRC is elevated in asthmatics, especially during the acute phase of an asthmatic attack [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/14\">",
"     14",
"    </a>",
"    ]. Several mechanisms are probably involved, but persistent or tonic activity of the inspiratory muscles is largely responsible for the rise in FRC [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/15\">",
"     15",
"    </a>",
"    ]. The increase in FRC is important, because this hyperinflation is thought to be responsible for sensations of chest tightness and dyspnea [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Total lung capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TLC can either be normal or elevated. If elevated, it is usually associated with more severe airflow limitation or disease of longer duration. The likely physiological mechanism is a loss of lung recoil combined with increased outward recoil of the chest wall and increased inspiratory muscle strength [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of",
"    <span class=\"nowrap\">",
"     RV/TLC",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     FRC/TLC",
"    </span>",
"    ratios can be quite helpful in patients for whom predicted values of the individual measurements are less reliable, eg, young children or patients with unusual ethnic origins. The",
"    <span class=\"nowrap\">",
"     RV/TLC",
"    </span>",
"    is generally high, but must be greater than approximately 150 percent of predicted before it can be considered to be abnormal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFUSING CAPACITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with asthma, the diffusing capacity (also called the transfer factor) for carbon monoxide (DLCO) is usually either normal or high, and the degree of elevation is related to asthma severity. The mechanisms potentially explaining this elevation are either [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2,18,19\">",
"     1,2,18,19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An increase in negative intrathoracic pressure during inspiration, which draws blood into the thorax.",
"     </li>",
"     <li>",
"      Improved ventilation-perfusion matching due to increased perfusion of the apices.",
"     </li>",
"     <li>",
"      Hemoglobin extravasation due to the inflammatory process, although evidence that this occurs is lacking.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The DLCO is most commonly determined by having the patient inhale a known volume of gas containing a low concentration of carbon monoxide (CO) and a known amount of helium. The patient then holds his or her breath for approximately 10 seconds. The expired gas is sampled during exhalation for determination of the loss of CO during the breath hold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main reason to perform a DLCO measurement in an asthmatic patient is to distinguish between other causes of reversible airflow limitation and asthma (",
"    <a class=\"graphic graphic_table graphicRef68527 \" href=\"UTD.htm?5/15/5371\">",
"     table 1",
"    </a>",
"    ). As an example, patients who have COPD may present with a misdiagnosis of asthma; however, the DLCO should be decreased in emphysema, but not asthma. Measurement of the DLCO may also be useful in medicolegal situations, in which an employee who smokes cigarettes has a claim against an employer for occupational asthma. An increase in DLCO may be supportive of the diagnosis of asthma as opposed to COPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OTHER PULMONARY FUNCTION TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other pulmonary function tests that can be considered in special situations are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Assessment of respiratory muscle function.",
"     </li>",
"     <li>",
"      Assessment of lung function which does not require patient effort.",
"     </li>",
"     <li>",
"      Assessment of control of breathing.",
"     </li>",
"     <li>",
"      Determination of lung static recoil.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Respiratory muscle function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory muscle assessment is most often limited to measurement of maximal",
"    <span class=\"nowrap\">",
"     inspiratory/expiratory",
"    </span>",
"    mouth pressures, although other measurements can also be performed. The usual indication for these tests is to determine the cause of submaximal muscular output when spirometry is suboptimal or questionable [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Lung volumes are also a clue to poor effort, which is suggested by a high RV and a low TLC (",
"    <a class=\"graphic graphic_figure graphicRef64766 \" href=\"UTD.htm?21/52/22350\">",
"     figure 5",
"    </a>",
"    ). Maximal pressures or lung volumes can be helpful in patients on oral steroid treatment, for whom a steroid myopathy may be suspected. Finally, distinguishing respiratory muscle abnormalities from poor effort may be important in medical-legal situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Tests not requiring patient effort",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of lung functions such as FEV1 requires that the patient perform FVC maneuvers reproducibly and with maximal effort; however, this is not always the case. There are a number of other techniques which yield similar information about airways function but do not require patient effort. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Forced oscillations",
"     </li>",
"     <li>",
"      Acoustic reflectance",
"     </li>",
"     <li>",
"      Interrupter techniques",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of these techniques is indicated in patients who cannot or will not perform the standard tests, such as the very young or old, and patients with steroid myopathy. However, these measures have not been applied to large populations to generate predicted values, or the endpoints show high variability. As a result, the response of these indices to bronchodilators or",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"      methacholine",
"     </a>",
"     /exercise",
"    </span>",
"    takes on more importance than does an isolated baseline result.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Control of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of the ventilatory response to low oxygen (hypoxia) or high CO2 (hypercapnia) assesses the ability of the body to respond to respiratory stimuli. It has been shown in severe asthmatics that there is reduced hypoxic responsiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/21\">",
"     21",
"    </a>",
"    ]. The indication for assessing the control of breathing is to clarify and identify those patients at risk for near-fatal asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Lung static recoil",
"    </span>",
"    &nbsp;&mdash;&nbsp;While it is generally believed that asthma causes a parallel upward shift of the pressure-volume (PV) curve of the lung [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/22\">",
"     22",
"    </a>",
"    ], several studies have demonstrated a loss of elastic recoil, ie, decreased static recoil pressure at a given volume [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/23\">",
"     23",
"    </a>",
"    ]. Measurement of the static recoil of the lung is accomplished through determination of the PV relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Static recoil is important because maximal expiratory flow, as measured with the FEV1 or flow-volume relationship, is determined both by airways caliber and by the driving pressure for expiratory flow, which is the static recoil of the lung [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therefore, determination of the PV relationship is indicated in a patient in whom the cause for a fall in FEV1 is unclear or needs to be clarified [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. There are both diagnostic and therapeutic implications to such PV determinations, based on which of the following factors is responsible for airflow limitation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Excessive dynamic airway compression or collapse",
"     </li>",
"     <li>",
"      Loss of static recoil",
"     </li>",
"     <li>",
"      Narrowing of the airways.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first situation is treated with pursed lip breathing or CPAP, whereas the only options for \"curing\" the second situation are lung transplantation or perhaps volume-reduction surgery for selected patients. The third setting, of course, is commonly treated with bronchodilators or corticosteroids.",
"   </p>",
"   <p>",
"    An example of a situation in which a PV curve is helpful is when the patient has both emphysema and asthma, and maximal treatment has resulted in some but not total improvement of lung function. A similar situation exists for the elderly patient who has a loss of elastic recoil due to aging of the lung. The PV analysis can then reveal whether there is still room for improvement (if the recoil is normal) or if no further improvement is possible (if the recoil is low).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following sequence of tests is suggested for the evaluation of patients who have asthma or are suspected of having asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22487/abstract/24\">",
"     24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Virtually all patients being treated for asthma should have a baseline spirometry; spirometry should be repeated annually or more often. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Spirometry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who need a more complete physiologic evaluation because the diagnosis is not clear, we obtain flow-volume loops (inspiratory and expiratory), both before and after the administration of a bronchodilator. In patients with asthma, the flow volume loop should show airflow limitation without evidence of other forms of obstruction (such as fixed obstruction), and may also demonstrate a significant bronchodilator response. The presence of normal airflow but a significant bronchodilator response is consistent with mild, reversible airflow limitation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Measures of airflow limitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If one finds normal airflow without a bronchodilator response, then bronchoprovocation challenge testing may be useful. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Bronchoprovocation challenge'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lung volume measurements are indicated when the results from the above tests are suggestive of other processes or the initial studies are equivocal. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Lung volumes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diffusing capacity should be determined in older patients, or those who smoke cigarettes or are exposed to respirable particles, gases, or fumes. The diffusing capacity is usually normal or elevated in patients with asthma and decreased in these other settings. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diffusing capacity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Difficulty performing the effort-dependent tests or medical-legal considerations may indicate the need for either a neuromuscular evaluation or tests which do not require maximal patient effort, such as measurement of specific conductance by plethysmography or respiratory resistance with forced oscillations. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Other pulmonary function tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/1\">",
"      Irvin, CG, Cherniack, RM. Pathophysiology and physiologic assessment of the asthmatic patient. Semin Respir Med 1987; 8:201.",
"     </a>",
"    </li>",
"    <li>",
"     Wagers, S, Jaffe, EF, Irvin, CG. Development, Structure, and Physiology in Normal and Asthmatic Lung. In: Middleton's allergy principles and practice, 6th Ed, Adkinson, NF Jr, Busse, WW, Yunginger, JW, et al (Eds), Elsevier, St Louis 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/3\">",
"      Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. Asthma outcome. Am J Respir Crit Care Med 1994; 149:S9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/4\">",
"      Crapo RO. Pulmonary-function testing. N Engl J Med 1994; 331:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/5\">",
"      Pennock BE, Cottrell JJ, Rogers RM. Pulmonary function testing. What is 'normal'? Arch Intern Med 1983; 143:2123.",
"     </a>",
"    </li>",
"    <li>",
"     National Asthma Education and Prevention Program: Expert Panel Report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD. National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). Available from www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. (Accessed April 11, 2008).",
"    </li>",
"    <li>",
"     U.S. Department of Health and Human Services. International consensus report on diagnosis and treatment of asthma. U.S. Government Printing Office, Washington D.C. PHHS Publication No. 92-3091, 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/8\">",
"      Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/9\">",
"      Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/10\">",
"      Smith HR, Irvin CG, Cherniack RM. The utility of spirometry in the diagnosis of reversible airways obstruction. Chest 1992; 101:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/11\">",
"      Brown RH, Pearse DB, Pyrgos G, et al. The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol 2006; 101:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/12\">",
"      Quadrelli SA, Roncoroni AJ, Montiel GC. Evaluation of bronchodilator response in patients with airway obstruction. Respir Med 1999; 93:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/13\">",
"      Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967; 22:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/14\">",
"      McFadden ER Jr, Kiser R, DeGroot WJ. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med 1973; 288:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/15\">",
"      Martin J, Powell E, Shore S, et al. The role of respiratory muscles in the hyperinflation of bronchial asthma. Am Rev Respir Dis 1980; 121:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/16\">",
"      Kraft M, Cairns CB, Ellison MC, et al. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006; 130:1726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/17\">",
"      Peress L, Sybrecht G, Macklem PT. The mechanism of increase in total lung capacity during acute asthma. Am J Med 1976; 61:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/18\">",
"      Collard P, Njinou B, Nejadnik B, et al. Single breath diffusing capacity for carbon monoxide in stable asthma. Chest 1994; 105:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/19\">",
"      Desjardin JA, Sutarik JM, Suh BY, Ballard RD. Influence of sleep on pulmonary capillary volume in normal and asthmatic subjects. Am J Respir Crit Care Med 1995; 152:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/20\">",
"      American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med 1995; 152:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/21\">",
"      Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/22\">",
"      Finucane KE, Colebatch HJ. Elastic behavior of the lung in patients with airway obstruction. J Appl Physiol 1969; 26:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22487/abstract/23\">",
"      Gold WM, Kaufman HS, Nadel JA. Elastic recoil of the lungs in chronic asthmatic patients before and after therapy. J Appl Physiol 1967; 23:433.",
"     </a>",
"    </li>",
"    <li>",
"     Irvin, CG. Evaluation of Pulmonary Function. In: Physiologic Basis of Respiratory Disease, Hamid, Q, Martin, J, Shannon, J (Eds), Dekker, Ontario 2005.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 569 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-4554544F47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22487=[""].join("\n");
var outline_f21_61_22487=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEASURES OF AIRFLOW LIMITATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Peak expiratory flow rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Spirometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Flow-volume relationships",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Bronchodilator responses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bronchoprovocation challenge",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LUNG VOLUMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Measurement of functional residual capacity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Residual volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Functional residual capacity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Total lung capacity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFUSING CAPACITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OTHER PULMONARY FUNCTION TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Respiratory muscle function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Tests not requiring patient effort",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Control of breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Lung static recoil",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/569\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/569|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/21/14686\" title=\"figure 1\">",
"      Diary record of PEFR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/30/11759\" title=\"figure 2\">",
"      Airflow limitation curves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/16/23822\" title=\"figure 3\">",
"      FV curves after treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/28/39373\" title=\"figure 4\">",
"      Lung volume and capacities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/52/22350\" title=\"figure 5\">",
"      Lung volumes by state",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/569|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/15/5371\" title=\"table 1\">",
"      Diffusing capacity limitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=related_link\">",
"      Bronchoprovocation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25878?source=related_link\">",
"      Flow-volume loops",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5607?source=related_link\">",
"      Office spirometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/53/854?source=related_link\">",
"      Peak expiratory flow rate monitoring in asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22488="Echo pulmonary atresia with intact VS";
var content_f21_61_22488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F88540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F88540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 615px\">",
"   <div class=\"ttl\">",
"    Echocardiographic images of pulmonary atresia with intact ventricular septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 595px; height: 490px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Echocardiogram in a fetus at&nbsp;32 weeks gestation with pulmonary atresia and intact ventricular septum (PA/IVS) demonstrates the normally formed aortic arch with a vertical ductus arteriosus&nbsp;(*). In the normal fetus, the ductus arteriosus lies in a more horizontal plane as it carries blood from the main pulmonary artery to the descending aorta. In the fetus with PA/IVS, the ductus arteriosus provides retrograde pulmonary blood flow and it lies in a more vertical position.",
"    <br>",
"     (B) Four-chamber view in a fetus at 32 weeks gestation&nbsp;with PA/IVS demonstrating a severely hypoplastic RV and shunting of blood from the RA through the foramen ovale (*)&nbsp;to the LA and LV.",
"     <br>",
"      (C) Four-chamber view in a neonate with PA/IVS demonstrating a small tricuspid valve and&nbsp;RV compared with the normally sized mitral valve and LV.",
"      <br>",
"       (D) Four-chamber view in a neonate with PA/IVS with measurements of the tricuspid and mitral valves. Note the small tricuspid valve (measurement 1) and RV compared with the normally sized mitral valve (measurement 2) and LV; the tricuspid valve measures 0.3 centimeters, which correlates to a Z-score of approximately &ndash;4.",
"       <div class=\"footnotes\">",
"        RA: right atrium; LA: left atrium; RV: right ventricle; LV: left ventricle.",
"       </div>",
"       <div class=\"reference\">",
"        Courtesy of Rajesh Punn, MD",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22488=[""].join("\n");
var outline_f21_61_22488=null;
var title_f21_61_22489="Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas";
var content_f21_61_22489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22489/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22489/contributors\">",
"     Peter J Snyder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22489/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22489/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22489/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22489/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/61/22489/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with pituitary adenomas present with signs and symptoms of hormone hypersecretion (eg, hyperprolactinemia, growth hormone excess, or hypercortisolism). However, 25 to 30 percent of pituitary adenomas are clinically nonfunctioning or &ldquo;silent&rdquo;; 80 to 90 percent of these are gonadotroph adenomas, making them the most common type of pituitary macroadenoma. Patients with clinically nonfunctioning adenomas most often present with neurologic symptoms due to mass effects, while others may be completely asymptomatic and be first detected on an imaging study done for reasons other than pituitary symptoms or disease. By the time patients present, a high percentage has biochemical evidence of hypopituitarism due to compression of normal pituitary cells by the macroadenoma.",
"   </p>",
"   <p>",
"    The clinical features, evaluation, and diagnosis of clinically nonfunctioning pituitary adenomas are reviewed here. The treatment of these tumors and an overview of incidentally discovered sellar masses (pituitary incidentalomas) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8857?source=see_link\">",
"     \"Treatment of gonadotroph and other clinically nonfunctioning adenomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=see_link\">",
"     \"Incidentally discovered sellar masses (pituitary incidentalomas)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96695262\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pituitary adenomas are classified by their cell of origin (lactotroph, gonadotroph, somatotroph, corticotroph, and thyrotroph) and their size (microadenomas &lt;1 cm, macroadenomas &ge;1 cm). Most adenomas (65 to 70 percent) secrete an excess amount of hormone including prolactin, growth hormone, ACTH, or TSH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link\">",
"     \"Causes of hyperprolactinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=see_link\">",
"     \"Causes and clinical manifestations of acromegaly\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=see_link\">",
"     \"Causes and pathophysiology of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/20/327?source=see_link\">",
"     \"Thyrotropin (TSH)-secreting pituitary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The remainder of pituitary adenomas (30 to 35 percent) are clinically nonfunctioning or &ldquo;silent&rdquo;. Of these, 80 to 90 percent are gonadotroph adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/1\">",
"     1",
"    </a>",
"    ]. There are also clinically nonfunctioning somatotroph [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], lactotroph, and corticotroph adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/4\">",
"     4",
"    </a>",
"    ], although these are less common.",
"   </p>",
"   <p>",
"    The majority of gonadotroph adenomas are clinically &ldquo;silent&rdquo; and difficult to identify because they are poorly differentiated and produce and secrete hormones inefficiently. The gonadotropins, LH and FSH, consist of a common alpha subunit, and a unique beta subunit. The hormones secreted by gonadotroph adenomas in order of decreasing frequency include: FSH, FSH-&beta;, alpha subunit, LH, and LH-&beta; [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/5\">",
"     5",
"    </a>",
"    ]. Gonadotropin subunits are not biologically active and clinical syndromes due to hypersecretion of intact gonadotropins (LH and FSH) and their subunits do occur, but they are uncommon. (See",
"    <a class=\"local\" href=\"#H333794\">",
"     'Gonadotroph adenomas: hormone excess'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H333975\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the prevalence of pituitary adenomas are variable, and are often based upon autopsy or MRI series. In a report from a single community of over 80,000 inhabitants in England, the prevalence of nonfunctioning pituitary adenomas (that had come to the attention of a clinician) was 22 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/6\">",
"     6",
"    </a>",
"    ]. This is likely an underestimate of the true prevalence, as many nonfunctioning pituitary adenomas go undiagnosed until they are very large or are identified on an imaging study done for unrelated reasons.",
"   </p>",
"   <p>",
"    Gonadotroph adenomas are thought to be most common in men over age 50 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/1\">",
"     1",
"    </a>",
"    ], and less common in similar aged women, but this could be due to difficulty in recognizing gonadotroph adenomas in this population. High serum gonadotropins would be unlikely to raise suspicion for a gonadotroph adenoma in a woman over 50, since she is likely to have elevated basal serum gonadotropin concentrations from the normal menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=see_link\">",
"     \"Clinical manifestations and diagnosis of menopause\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H291836653\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadotroph adenomas, like other pituitary adenomas, appear to be true clonal neoplasms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], but the mutations that cause them are not known. Genes that have been found to be overexpressed include the pituitary tumor transforming gene, Ki-67, and FGF-R [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. The maternally-expressed gene 3 (MEG3) is underexpressed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonfunctioning pituitary adenomas (including the majority of gonadotroph adenomas) are difficult to recognize clinically until they are large enough to cause symptoms due to a mass effect. The three most common presentations include the following (",
"    <a class=\"graphic graphic_table graphicRef58084 \" href=\"UTD.htm?19/53/20315\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurologic symptoms, most commonly visual symptoms; less commonly headache.",
"     </li>",
"     <li>",
"      A pituitary mass that is discovered as an incidental finding when an imaging procedure is done for reasons other than pituitary symptoms or disease.",
"     </li>",
"     <li>",
"      Pituitary hypofunction due to compression of normal pituitary tissue by the adenoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less commonly, patients with gonadotroph adenomas may present with clinical syndromes due to hypersecretion of FSH or, less commonly, LH (ovarian hyperstimulation or precocious puberty). (See",
"    <a class=\"local\" href=\"#H333794\">",
"     'Gonadotroph adenomas: hormone excess'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Neurologic symptoms",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H177771361\">",
"    <span class=\"h3\">",
"     Visual impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired vision, caused by suprasellar extension of the adenoma that compresses the optic chiasm, is the most common symptom that leads a patient with a gonadotroph or other clinically nonfunctioning adenoma to seek medical attention (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87693 \" href=\"UTD.htm?38/27/39345\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common type of vision impairment is visual field loss, typically diminished vision in the temporal fields (superior temporal quadrantanopsia or temporal hemianopsia). One or both eyes may be affected. In a review of eight series of 1719 patients with clinically nonfunctioning pituitary adenomas, visual field disturbances were present in 798 (46 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"       14",
"      </a>",
"      ], while in a single center series of 295 patients, the frequency was even higher (192 of 295, 65 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diminished visual acuity, which occurs when the optic chiasm is more severely compressed [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/16\">",
"       16",
"      </a>",
"      ], was reported in approximately 30 percent of patients in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/15\">",
"       15",
"      </a>",
"      ]. Thus, an intrasellar lesion should be suspected when there is any unexplained pattern of visual loss.",
"     </li>",
"     <li>",
"      The onset of visual deficits is usually so gradual that many patients do not seek ophthalmologic consultation for months or even years.",
"     </li>",
"     <li>",
"      Diplopia, induced by oculomotor nerve compression resulting from lateral extension of the adenoma may occur, but is less common, occurring in up to 10 to 15 percent of patients in several large series [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H177771368\">",
"    <span class=\"h3\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headaches, the second most common neurologic symptom, occur in 30 to 40 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], and are thought to be due to sellar expansion. There is no distinguishing characteristic of the headaches, although they are usually diffuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H177771375\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other less common neurologic symptoms include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebrospinal fluid rhinorrhea, caused by inferior extension of the adenoma, rarely occurs spontaneously [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pituitary apoplexy (sudden hemorrhage into a pituitary macroadenoma), is also rare. It causes excruciating headache and visual impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/18\">",
"       18",
"      </a>",
"      ]. This may occur spontaneously, but has also been reported during pregnancy, surgery, and with anticoagulant use [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/19\">",
"       19",
"      </a>",
"      ]. It has been described less commonly after thyrotropin-releasing hormone (TRH) and gonadotropin-releasing hormone (GnRH) stimulation tests [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/20,21\">",
"       20,21",
"      </a>",
"      ] and with gonadotropin-releasing hormone (GnRH) agonist therapy for prostate cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Incidental finding on imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common use of magnetic resonance imaging to evaluate symptoms in the head or neck has resulted in the incidental discovery of many intrasellar lesions. In two MRI series of 100 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/24\">",
"     24",
"    </a>",
"    ] and 52 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/25\">",
"     25",
"    </a>",
"    ] normal volunteers, 10 (10 percent) and 25 (38 percent), respectively, had previously unsuspected sellar lesions, but almost all were &lt;10 mm. However, in one review of eight series of pituitary &ldquo;incidentalomas&rdquo; discovered on MRI, 68 percent were macroadenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"     14",
"    </a>",
"    ]. This percentage is much higher than other imaging series, suggesting that patients likely had symptoms suggestive of a sellar mass that led to the imaging study.",
"   </p>",
"   <p>",
"    The evaluation and management of these adenomas are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=see_link\">",
"     \"Incidentally discovered sellar masses (pituitary incidentalomas)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Symptoms due to hormonal abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically nonfunctioning adenomas often present with evidence of hypopituitarism (usually biochemical). On rare occasions, gonadotroph adenomas present with hormonal hypersecretion causing a clinical syndrome such as ovarian hyperstimulation or precocious puberty.",
"   </p>",
"   <p>",
"    Gonadotroph adenomas, like all other types of pituitary adenomas, can occur as part of the MEN-1 syndrome, a rare heritable disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary, and pancreatic islet cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17174?source=see_link&amp;anchor=H4#H4\">",
"     \"Multiple endocrine neoplasia type 1: Definition and genetics\", section on 'MEN1 gene'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H280094\">",
"    <span class=\"h3\">",
"     Hormone deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who present with neurologic symptoms, when carefully questioned, may acknowledge symptoms of pituitary hormone deficiencies that are due to compression of nonadenomatous cells by the macroadenoma. However, these symptoms tend to be nonspecific (fatigue and lethargy), and are not usually the reason that the patient seeks medical attention.",
"   </p>",
"   <p>",
"    The most common clinical hormone deficiency is impaired secretion of gonadotropins resulting in hypogonadism. In a series of 295 patients with nonfunctioning pituitary adenomas, 61 of 161 men (38 percent) had low serum gonadotropins, resulting in low serum testosterone, decreased libido, and erectile dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/15\">",
"     15",
"    </a>",
"    ]. In the same report, 33 percent of the women of reproductive age had menstrual cycle disorders.",
"   </p>",
"   <p>",
"    Higher percentages of hypopituitarism may be detected biochemically in patients with clinically nonfunctioning adenomas. In a review of eight series of 1719 patients, 993 (58 percent) had laboratory evidence of pituitary hormone deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"     14",
"    </a>",
"    ]. The most common pituitary hormone deficiencies were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Growth hormone (GH) (87 percent, 220 of 252 tested). Testing for GH deficiency was less common in older series, because GH deficiency was not thought to have important clinical consequences. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=see_link\">",
"       \"Growth hormone deficiency in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       LH/FSH",
"      </span>",
"      (hypogonadotropic hypogonadism: 1216 of 1699 patients tested, 72 percent).",
"     </li>",
"     <li>",
"      ACTH (secondary adrenal insufficiency: 514 of 1699, 30 percent).",
"     </li>",
"     <li>",
"      TSH (central hypothyroidism: 402 of 1699, 24 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H333794\">",
"    <span class=\"h3\">",
"     Gonadotroph adenomas: hormone excess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although gonadotroph adenomas are considered to be &ldquo;nonfunctioning&rdquo;, most do produce intact gonadotropins or their subunits. However, these adenomas are typically poorly differentiated and inefficient",
"    <span class=\"nowrap\">",
"     producers/secretors",
"    </span>",
"    and do not raise serum gonadotropin concentrations. Thus, they are usually clinically &ldquo;silent&rdquo; and cannot be distinguished from other clinically nonfunctioning adenomas until immunohistochemistry is performed after pituitary surgery.",
"   </p>",
"   <p>",
"    However, about 35 percent of gonadotroph adenomas secrete enough LH or FSH to raise serum gonadotropin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/26\">",
"     26",
"    </a>",
"    ], but clinical syndromes due to hypersecretion of intact gonadotropins are rare. However, several syndromes have been recognized (",
"    <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ovarian hyperstimulation has been reported in premenopausal women [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/27-33\">",
"       27-33",
"      </a>",
"      ] and rarely in prepubertal girls [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. The slight, but persistently, elevated serum FSH concentrations lead to recruitment of multiple dominant follicles, high serum estradiol concentrations (&gt;500",
"      <span class=\"nowrap\">",
"       pg/mL),",
"      </span>",
"      and thickened endometrium on pelvic ultrasound (potentially suggestive of endometrial hyperplasia). The clinical picture is similar to ovarian stimulation with exogenous FSH when administered for fertility treatment (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77302 \" href=\"UTD.htm?3/5/3157\">",
"       image 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Because the multiple follicles are not triggered to ovulate, women present with amenorrhea or oligomenorrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/27-33\">",
"       27-33",
"      </a>",
"      ], and prepubertal girls present with breast development, vaginal bleeding, and abdominal distension [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. If pituitary surgery is successful in removing the adenoma but not removing the normal pituitary, gonadotropin secretion and ovarian function returns to normal [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/32,36-39\">",
"       32,36-39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An LH-secreting pituitary adenoma resulting in precocious puberty has been reported in two boys [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/40,41\">",
"       40,41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although gonadotroph adenomas are thought to occur most commonly in middle-aged men, clinical findings due to hypersecretion of intact LH or FSH are rare in this group. However, elevated serum testosterone concentration due to hypersecretion of intact luteinizing hormone (LH) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/5,42\">",
"     5,42",
"    </a>",
"    ] and testicular enlargement due to FSH hypersecretion have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of gonadotroph adenomas that secrete intact gonadotropins occur in middle aged adults and do",
"    <strong>",
"     not",
"    </strong>",
"    result in a clinical syndrome. In postmenopausal women, for example, a gonadotroph adenoma that secretes intact gonadotropins would not result in a clinical syndrome, because gonadotropin levels are already high, and a postmenopausal ovary cannot be stimulated to produce follicles or estrogen.",
"   </p>",
"   <p>",
"    In postmenopausal women, a sellar mass can be recognized as a gonadotroph adenoma biochemically by the combination of an elevated FSH",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alpha subunit and a suppressed LH (",
"    <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/16\">",
"     16",
"    </a>",
"    ]. They can also be identified by an LH beta subunit response to TRH. As an example, 11 of 14 women with clinically nonfunctioning sellar masses exhibited an LH beta response to TRH [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/7\">",
"     7",
"    </a>",
"    ]. The sellar masses were shown to be gonadotroph adenomas by immunostaining of the excised tissue.",
"   </p>",
"   <p>",
"    In men, an intrasellar mass can be recognized as a gonadotroph adenoma by a supranormal basal serum FSH concentration (",
"    <a class=\"graphic graphic_figure graphicRef52535 \" href=\"UTD.htm?10/26/10671\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/44\">",
"     44",
"    </a>",
"    ]. An elevated concentration of alpha subunit indicates a gonadotroph adenoma, a thyrotroph adenoma, or less differentiated glycoprotein adenoma. A supranormal response of intact FSH and LH or LH beta subunit to exogenous thyrotropin releasing hormone (TRH) has also been described in men with gonadotroph adenomas.",
"   </p>",
"   <p>",
"    In one report of 38 men, as an example, increased response to TRH was seen in 14 for LH beta subunit and five each for intact FSH and LH [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/44\">",
"     44",
"    </a>",
"    ]. Enhanced responsiveness was not seen in growth hormone or prolactin secreting pituitary adenomas. TRH is currently unavailable in the United States, although it is available in many other countries, and LH- and FSH beta subunit assays are not widely available. Alpha subunit assays are widely available. In countries where TRH is available, an FSH response to TRH can be used to identify a gonadotroph adenoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406942372\">",
"    <span class=\"h3\">",
"     Elevated prolactin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macroadenomas often compress the pituitary stalk and obstruct the normal inhibitory hypothalamic influence on the prolactin producing cells, resulting in modestly elevated serum prolactin concentrations (usually &lt;100",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    but sometimes as high as 200",
"    <span class=\"nowrap\">",
"     ng/mL).",
"    </span>",
"    Illustrated in one study of 226 patients with nonfunctioning macroadenomas; a serum prolactin concentration &gt;94",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    reliably distinguished between lactotroph adenomas and nonfunctioning adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/45\">",
"     45",
"    </a>",
"    ]. Rarely gonadotroph adenomas co-secrete prolactin and gonadotropins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H280057\">",
"    <span class=\"h2\">",
"     Characteristic imaging features",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted, gonadotroph adenomas are generally hormonally inefficient; as a result, by the time a gonadotroph adenoma produces supranormal serum concentrations of intact gonadotropins or their subunits, it is a macroadenoma (&gt;1 cm) by imaging (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87693 \" href=\"UTD.htm?38/27/39345\">",
"     image 1",
"    </a>",
"    ). MRI in a patient with neurologic symptoms usually shows a large intrasellar mass that is frequently extending outside of the sella. Elevation of the optic chiasm or extension into the cavernous sinuses or sphenoid sinus can also be detected. MRI with gadolinium is preferred to CT because it provides superior resolution of the mass and its relation to surrounding structures. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pituitary imaging'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=see_link&amp;anchor=H24#H24\">",
"     \"Causes, presentation, and evaluation of sellar masses\", section on 'MRI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H280339\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our approach to the patient whose presenting signs, symptoms or prior imaging suggests a sellar mass includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Take a detailed history and perform a physical examination, recognizing that any visual abnormalities or other neurologic symptoms could represent a sellar mass. The history should also focus on possible symptoms of hypopituitarism, including symptoms of hypogonadism in men (fatigue, decreased libido, erectile dysfunction) and women",
"      <span class=\"nowrap\">",
"       (amenorrhea/oligomenorrhea).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Neurologic symptoms'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H280094\">",
"       'Hormone deficiencies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Confirm the presence of a sellar mass by an MRI dedicated to this region if not already done. If a sellar mass is confirmed, assess its size, relationship to chiasm and cavernous sinuses.",
"     </li>",
"     <li>",
"      Perform visual field and visual acuity testing (see",
"      <a class=\"local\" href=\"#H335448\">",
"       'Visual field testing'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Perform biochemical testing to detect other kinds of pituitary adenomas by their excessive hormonal secretion (eg, lactotroph, somatotroph and, less commonly, corticotroph adenomas) (see",
"      <a class=\"local\" href=\"#H406941235\">",
"       'Hormone hypersecretion'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Test for excessive secretion of gonadotropins and their subunits, as they are characteristic of gonadotroph adenomas. This includes measurement of serum LH, FSH, and alpha subunit concentrations (see",
"      <a class=\"local\" href=\"#H406941235\">",
"       'Hormone hypersecretion'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Test also for pituitary hypofunction due to compression of normal pituitary cells by the adenoma (see",
"      <a class=\"local\" href=\"#H406942910\">",
"       'Hypopituitarism'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Endocrine Society Clinical Practice Guidelines on Pituitary Incidentaloma agree with our approach and suggest MRI, visual field testing and biochemical evaluation for hormone hypersecretion and hypopituitarism for patients with pituitary incidentalomas that are &gt;1 cm in size [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pituitary imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest magnetic resonance imaging (MRI) for the initial imaging study for suspected adenomas, because of its superior resolution and its ability to demonstrate the optic chiasm. MRI is also able to detect blood, thereby permitting recognition of hemorrhage into the pituitary and distinction of an aneurysm from other intrasellar lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87693 \" href=\"UTD.htm?38/27/39345\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    MRI in a symptomatic patient usually shows a large intrasellar mass that is frequently extending outside of the sella. Elevation of the optic chiasm or extension into the cavernous sinuses or sphenoid sinus can also be detected. However, MRI will not distinguish adenomatous tissue from normal pituitary tissue. MRI will also not distinguish a gonadotroph adenoma from other pituitary macroadenomas and often not even from nonpituitary lesions. This topic is reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=see_link&amp;anchor=H24#H24\">",
"     \"Causes, presentation, and evaluation of sellar masses\", section on 'MRI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335448\">",
"    <span class=\"h2\">",
"     Visual field testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with sellar masses elevating the optic chiasm, including those who deny visual symptoms, should undergo baseline Humphrey visual field testing and evaluation of visual acuity. A clinician experienced in evaluating visual field abnormalities, such as a neuroophthalmologist, should interpret the results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H334287526\">",
"    <span class=\"h2\">",
"     Hormonal evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothalamic-pituitary hormonal function (both hyper- and hypofunction) should be evaluated whenever a large sellar mass is seen on MRI to determine if it is functioning or nonfunctioning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406941235\">",
"    <span class=\"h3\">",
"     Hormone hypersecretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of hormone excess should be evaluated to detect the presence of functioning pituitary adenomas. We therefore suggest measurements of serum prolactin (lactotroph adenomas), insulin-like growth factor-1 (IGF-1) (somatotroph adenomas), and 24-hour urine free cortisol (corticotroph adenomas).",
"   </p>",
"   <p>",
"    We also suggest measuring serum LH, FSH, and alpha subunit, because an elevated concentration of an intact gonadotropin or one of its subunits provides evidence for a gonadotroph adenoma, although normal or low levels do not exclude it (see",
"    <a class=\"local\" href=\"#H333794\">",
"     'Gonadotroph adenomas: hormone excess'",
"    </a>",
"    above). Measurement of alpha subunit is widely available, but assays for LH- and FSH-beta subunits are not. An FSH response to thyrotropin-releasing hormone (TRH) also indicates a gonadotroph adenoma (",
"    <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Finding evidence for a gonadotroph adenoma will not influence the choice of therapy (which is pituitary surgery), but recognizing that a sellar mass is a gonadotroph adenoma and not a nonpituitary lesion could influence the route of surgery and can be used as a tumor marker by which to evaluate the result of surgery and for subsequent monitoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406942910\">",
"    <span class=\"h3\">",
"     Hypopituitarism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficient secretion of other pituitary hormones often occurs due to the mass effect of the typically large gonadotroph adenomas and should always be investigated. Additional testing for hormone deficiencies due to compression of the normal pituitary tissue includes measurement of the serum concentrations of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      8 AM cortisol",
"     </li>",
"     <li>",
"      T4 (if elevated, measure TSH to evaluate the possibility of a thyrotroph adenoma)",
"     </li>",
"     <li>",
"      Testosterone in men",
"     </li>",
"     <li>",
"      Estradiol (E2) in women of premenopausal age with amenorrhea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The interpretation of pituitary tests and the diagnosis of hypopituitarism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=see_link\">",
"     \"Diagnosis of hypopituitarism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263258\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definitive diagnosis of a gonadotroph adenoma is made by pathologic evaluation of the excised tissue. Pituitary adenomas typically show effacement of the normal lobular pituitary architecture and instead show a monomorphic population of cells and loss of the normal reticulin pattern. Immunochemical staining is positive for FSH beta, LH beta,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alpha subunit.",
"   </p>",
"   <p>",
"    However, the diagnosis of a gonadotroph adenoma can be made with a reasonable degree of certainty preoperatively in a patient with a large sellar mass in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum prolactin concentration less than 100",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      (see",
"      <a class=\"local\" href=\"#H406942372\">",
"       'Elevated prolactin'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      No symptoms or signs of acromegaly and serum concentration of insulin-like growth factor-1 (IGF-1) not elevated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=see_link\">",
"       \"Causes and clinical manifestations of acromegaly\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43076?source=see_link\">",
"       \"Diagnosis of acromegaly\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No signs or symptoms of Cushing's syndrome and 24-hour urine cortisol excretion not elevated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"       \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=see_link\">",
"       \"Establishing the diagnosis of Cushing's syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In men, elevated basal serum concentrations of intact FSH",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      of alpha subunit (",
"      <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"       table 2",
"      </a>",
"      ). In countries where TRH is available, an FSH response to TRH. Rarely, elevated LH and testosterone. Elevated FSH and LH and subnormal testosterone indicate primary hypogonadism. (See",
"      <a class=\"local\" href=\"#H96694952\">",
"       'Primary hypogonadism'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In premenopausal women, irregular menses, elevated FSH and estradiol, low LH, and on pelvic ultrasound, massive polycystic ovaries and thickened endometrium.",
"     </li>",
"     <li>",
"      In postmenopausal women, elevated FSH",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alpha subunit and low LH (",
"      <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"       table 2",
"      </a>",
"      ). Elevation of both FSH and LH likely indicate only normal postmenopausal gonadotropin secretion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pituitary adenomas are the most common cause of a large sellar mass, but other causes include craniopharyngioma, meningioma, malignant tumors, Rathke&rsquo;s cleft cysts, and hypophysitis. Any sellar masses &gt;1 cm may present with neurologic symptoms similar to clinically nonfunctioning pituitary adenomas. Evaluation of a large sellar mass includes imaging with MRI, and hormonal evaluation for pituitary hyper- and hypofunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=see_link&amp;anchor=H22#H22\">",
"     \"Causes, presentation, and evaluation of sellar masses\", section on 'Evaluation of a sellar mass'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=see_link&amp;anchor=H7#H7\">",
"     \"Incidentally discovered sellar masses (pituitary incidentalomas)\", section on 'Lesions 10 mm or larger'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96694932\">",
"    <span class=\"h2\">",
"     Lactotroph macroadenoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, a large sellar mass associated with a prolactin concentration &lt;100",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    probably does not represent a lactotroph adenoma. Large sellar masses compress the pituitary stalk and thereby prevent dopamine from the hypothalamus from reaching the pituitary, thus decreasing normal inhibition of prolactin secretion. The result is a mild elevation of serum prolactin (&gt;20",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [eg, higher than normal] but usually &lt;100",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/45,47\">",
"     45,47",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H406942372\">",
"     'Elevated prolactin'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=see_link\">",
"     \"Clinical manifestations and diagnosis of hyperprolactinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96694952\">",
"    <span class=\"h2\">",
"     Primary hypogonadism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-standing primary hypogonadism can cause gonadotroph cell hypertrophy and therefore overall pituitary enlargement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/48,49\">",
"     48,49",
"    </a>",
"    ] and, in this way, as well as in elevated gonadotropin concentrations, is similar to gonadotroph adenomas. Primary hypogonadism differs from gonadotroph adenomas in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The degree of pituitary enlargement is much less",
"     </li>",
"     <li>",
"      Both LH and FSH are elevated",
"     </li>",
"     <li>",
"      Neither intact gonadotropins nor their subunits respond to TRH [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/44,50\">",
"       44,50",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406941432\">",
"    <span class=\"h2\">",
"     Polycystic ovary syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with polycystic ovary syndrome have multiple follicles on pelvic ultrasound. However, they are small and arranged in a peripheral pattern, unlike the follicles described in the cases of ovarian hyperstimulation syndrome in women with gonadotroph adenomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77302 \" href=\"UTD.htm?3/5/3157\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22489/abstract/27-33\">",
"     27-33",
"    </a>",
"    ]. In addition, serum FSH concentrations are low in PCOS, not normal or high as they would be with a gonadotroph adenoma. Lastly, a serum estradiol concentration &gt;500",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    should strongly raise the suspicion that the multiple ovarian cysts are due to a gonadotroph adenoma (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77302 \" href=\"UTD.htm?3/5/3157\">",
"     image 2",
"    </a>",
"    ) rather than polycystic ovary syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/28/7619?source=see_link\">",
"       \"Patient information: Pituitary adenoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1218774792\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 25 to 30 percent of all pituitary adenomas are clinically nonfunctioning or &ldquo;silent&rdquo;; 80 to 90 percent of these are gonadotroph adenomas (see",
"      <a class=\"local\" href=\"#H96695262\">",
"       'Overview'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Clinically nonfunctioning adenomas (including gonadotroph adenomas) usually come to clinical attention when they become large enough to cause neurologic symptoms such as impaired vision (diminished vision in the temporal fields [bitemporal hemianopsia], and diminished visual acuity), nonspecific headaches, diplopia, cerebrospinal fluid rhinorrhea, and pituitary apoplexy (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Neurologic symptoms'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Some are detected as an incidental finding when an MRI is done for other reasons (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Incidental finding on imaging'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Approximately 60 percent of patients at the time of diagnosis have hypopituitarism due to compression by the macroadenoma, but the hormonal deficiencies are usually not the presenting symptoms and not detected until the patient undergoes biochemical testing (see",
"      <a class=\"local\" href=\"#H280094\">",
"       'Hormone deficiencies'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Gonadotroph adenomas are difficult to recognize because they secrete variably and inefficiently, and the resulting products often do not cause a clinical syndrome. Only 35 percent secrete enough intact FSH or alpha subunit to raise their serum levels. Uncommonly, however, gonadotroph adenomas hypersecrete FSH in premenopausal women and cause ovarian hyperstimulation and, rarely, some hypersecrete LH in a boy or man and cause an increased serum testosterone concentration (see",
"      <a class=\"local\" href=\"#H333794\">",
"       'Gonadotroph adenomas: hormone excess'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Evaluation of the patient who presents with neurological symptoms suggestive of a clinically nonfunctioning sellar mass should include (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Evaluation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pituitary MRI",
"     </li>",
"     <li>",
"      Visual field testing",
"     </li>",
"     <li>",
"      Biochemical testing for hormone hypersecretion (serum prolactin, insulin-like growth factor-1 (IGF-1), and 24-hour urine free cortisol) (see",
"      <a class=\"local\" href=\"#H333794\">",
"       'Gonadotroph adenomas: hormone excess'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Testing for hypopituitarism: 8AM cortisol, T4 (plus TSH if the T4 is high), testosterone in men and estradiol in women of premenopausal age, FSH, LH and alpha subunit (see",
"      <a class=\"local\" href=\"#H406942910\">",
"       'Hypopituitarism'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of a gonadotroph adenoma is likely if there is a large sellar mass, no clinical or biochemical evidence of acromegaly or Cushing&rsquo;s syndrome, the serum prolactin is &lt;100",
"      <span class=\"nowrap\">",
"       ng/mL,",
"      </span>",
"      and the concentrations of gonadotropins are characteristic (",
"      <a class=\"graphic graphic_table graphicRef74280 \" href=\"UTD.htm?20/37/21083\">",
"       table 2",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H263258\">",
"       'Diagnosis'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In men, characteristic patterns are an elevated serum FSH",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alpha subunit or, rarely, elevated LH and testosterone.",
"     </li>",
"     <li>",
"      In women of premenopausal age, characteristic patterns are an elevated FSH, with or without alpha subunit, and estradiol.",
"     </li>",
"     <li>",
"      In postmenopausal women, the patterns are an elevated FSH",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alpha subunit but low LH. The diagnosis is confirmed if histologic examination of the excised tissue shows a pituitary adenoma and immunocytochemical staining shows staining for FSH, LH,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alpha subunit.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/1\">",
"      Chaidarun SS, Klibanski A. Gonadotropinomas. Semin Reprod Med 2002; 20:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/2\">",
"      Sakharova AA, Dimaraki EV, Chandler WF, Barkan AL. Clinically silent somatotropinomas may be biochemically active. J Clin Endocrinol Metab 2005; 90:2117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/3\">",
"      Wade AN, Baccon J, Grady MS, et al. Clinically silent somatotroph adenomas are common. Eur J Endocrinol 2011; 165:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/4\">",
"      Ioachimescu AG, Eiland L, Chhabra VS, et al. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 2012; 71:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/5\">",
"      Chamoun R, Layfield L, Couldwell WT. Gonadotroph Adenoma with Secondary Hypersecretion of Testosterone. World Neurosurg 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/6\">",
"      Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2010; 72:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/7\">",
"      Daneshdoost L, Gennarelli TA, Bashey HM, et al. Recognition of gonadotroph adenomas in women. N Engl J Med 1991; 324:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/8\">",
"      Alexander JM, Biller BM, Bikkal H, et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 1990; 86:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/9\">",
"      Herman V, Fagin J, Gonsky R, et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990; 71:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/10\">",
"      Zhang X, Horwitz GA, Heaney AP, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 1999; 84:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/11\">",
"      Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 2007; 28:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/12\">",
"      Ram&iacute;rez C, Cheng S, Vargas G, et al. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study. J Clin Endocrinol Metab 2012; 97:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/13\">",
"      Gejman R, Batista DL, Zhong Y, et al. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008; 93:4119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/14\">",
"      Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 2008; 37:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/15\">",
"      Ferrante E, Ferraroni M, Castrignan&ograve; T, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 2006; 155:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/16\">",
"      Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985; 6:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/17\">",
"      Lam G, Mehta V, Zada G. Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature. Neurosurg Focus 2012; 32:E2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/18\">",
"      Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med 2008; 23:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/19\">",
"      Semple PL, Jane JA Jr, Laws ER Jr. Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 2007; 61:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/20\">",
"      Szabolcs I, K&eacute;sm&aacute;rki N, Bor K, et al. Apoplexy of a pituitary macroadenoma as a severe complication of preoperative thyrotropin-releasing hormone (TRH) testing. Exp Clin Endocrinol Diabetes 1997; 105:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/21\">",
"      Frankart L, De Hertogh R, Donckier J, et al. [Pituitary apoplexy of a gonadotrophinoma and TRH/GnRH tests. Literature review]. Acta Clin Belg 1995; 50:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/22\">",
"      Massoud W, Paparel P, Lopez JG, et al. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer. Int J Urol 2006; 13:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/23\">",
"      Guerra Y, Lacuesta E, Marquez F, et al. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer. Pituitary 2010; 13:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/24\">",
"      Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/25\">",
"      Chong BW, Kucharczyk W, Singer W, George S. Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. AJNR Am J Neuroradiol 1994; 15:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/26\">",
"      Ho DM, Hsu CY, Ting LT, Chiang H. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Hum Pathol 1997; 28:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/27\">",
"      Djerassi A, Coutifaris C, West VA, et al. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 1995; 80:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/28\">",
"      Christin-Maitre S, Rongi&egrave;res-Bertrand C, Kottler ML, et al. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab 1998; 83:3450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/29\">",
"      V&auml;lim&auml;ki MJ, Tiitinen A, Alfthan H, et al. Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman. J Clin Endocrinol Metab 1999; 84:4204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/30\">",
"      Pentz-Vidov&iacute;c I, Skori T, Grubisi G, et al. Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation. Eur J Endocrinol 2000; 143:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/31\">",
"      Shimon I, Rubinek T, Bar-Hava I, et al. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 2001; 86:3635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/32\">",
"      Castelbaum AJ, Bigdeli H, Post KD, et al. Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril 2002; 78:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/33\">",
"      Murata Y, Ando H, Nagasaka T, et al. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 2003; 88:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/34\">",
"      Tashiro H, Katabuchi H, Ohtake H, et al. A follicle-stimulating hormone-secreting gonadotroph adenoma with ovarian enlargement in a 10-year-old girl. Fertil Steril 1999; 72:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/35\">",
"      Gryngarten MG, Braslavsky D, Ballerini MG, et al. Spontaneous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macroadenoma in an early pubertal girl. Horm Res Paediatr 2010; 73:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/36\">",
"      Murakami T, Higashitsuji H, Yoshinaga K, et al. Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma. BJOG 2004; 111:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/37\">",
"      Sugita T, Seki K, Nagai Y, et al. Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest 2005; 59:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/38\">",
"      Roberts JE, Spandorfer S, Fasouliotis SJ, et al. Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma. Fertil Steril 2005; 83:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/39\">",
"      Mor E, Rodi IA, Bayrak A, et al. Diagnosis of pituitary gonadotroph adenomas in reproductive-aged women. Fertil Steril 2005; 84:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/40\">",
"      Faggiano M, Criscuolo T, Perrone L, et al. Sexual precocity in a boy due to hypersecretion of LH and prolactin by a pituitary adenoma. Acta Endocrinol (Copenh) 1983; 102:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/41\">",
"      Ambrosi B, Bassetti M, Ferrario R, et al. Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: hormonal and immunocytochemical studies. Acta Endocrinol (Copenh) 1990; 122:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/42\">",
"      Snyder PJ, Sterling FH. Hypersecretion of LH and FSH by a pituitary adenoma. J Clin Endocrinol Metab 1976; 42:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/43\">",
"      Dahlqvist P, Koskinen LO, Br&auml;nnstr&ouml;m T, H&auml;gg E. Testicular enlargement in a patient with a FSH-secreting pituitary adenoma. Endocrine 2010; 37:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/44\">",
"      Daneshdoost L, Gennarelli TA, Bashey HM, et al. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993; 77:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/45\">",
"      Karavitaki N, Thanabalasingham G, Shore HC, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 2006; 65:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/46\">",
"      Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/47\">",
"      Hansen KA, Tho SP, Gomez F, McDonough PG. Nonfunctioning pituitary macroadenoma presenting with mild hyperprolactinemia and amenorrhea. Fertil Steril 1999; 72:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/48\">",
"      Dadachanji MC, Bharucha NE, Jhankaria BG. Pituitary hyperplasia mimicking pituitary tumor. Surg Neurol 1994; 42:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/49\">",
"      Samaan NA, Stepanas AV, Danziger J, Trujillo J. Reactive pituitary abnormalities in patients with Klinefelter's and Turner's syndromes. Arch Intern Med 1979; 139:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22489/abstract/50\">",
"      Snyder PJ, Bashey HM, Kim SU, Chappel SC. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. J Clin Endocrinol Metab 1984; 59:1169.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6627 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-2ED5F37753-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22489=[""].join("\n");
var outline_f21_61_22489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1218774792\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96695262\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H333975\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H291836653\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Neurologic symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H177771361\">",
"      - Visual impairment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H177771368\">",
"      - Headache",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H177771375\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Incidental finding on imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Symptoms due to hormonal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H280094\">",
"      - Hormone deficiencies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H333794\">",
"      - Gonadotroph adenomas: hormone excess",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H406942372\">",
"      - Elevated prolactin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H280057\">",
"      Characteristic imaging features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H280339\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pituitary imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H335448\">",
"      Visual field testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H334287526\">",
"      Hormonal evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H406941235\">",
"      - Hormone hypersecretion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H406942910\">",
"      - Hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H263258\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96694932\">",
"      Lactotroph macroadenoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96694952\">",
"      Primary hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406941432\">",
"      Polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1218774792\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/6627\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6627|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/27/39345\" title=\"diagnostic image 1\">",
"      MRI large sellar mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/5/3157\" title=\"diagnostic image 2\">",
"      U-S ovary gonadotroph adenoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6627|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/26/10671\" title=\"figure 1\">",
"      Hormones gonadotroph adenoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6627|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/53/20315\" title=\"table 1\">",
"      Sx of gonadotroph adenomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/37/21083\" title=\"table 2\">",
"      Diagnosis gonadotroph adenoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=related_link\">",
"      Causes and clinical manifestations of acromegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=related_link\">",
"      Causes and pathophysiology of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=related_link\">",
"      Causes of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=related_link\">",
"      Causes, presentation, and evaluation of sellar masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=related_link\">",
"      Clinical manifestations and diagnosis of menopause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43076?source=related_link\">",
"      Diagnosis of acromegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=related_link\">",
"      Diagnosis of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=related_link\">",
"      Establishing the diagnosis of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=related_link\">",
"      Growth hormone deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=related_link\">",
"      Incidentally discovered sellar masses (pituitary incidentalomas)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17174?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Definition and genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/28/7619?source=related_link\">",
"      Patient information: Pituitary adenoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/20/327?source=related_link\">",
"      Thyrotropin (TSH)-secreting pituitary adenomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8857?source=related_link\">",
"      Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22490="Emergent evaluation of the child with acute abdominal pain";
var content_f21_61_22490=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergent evaluation of the child with acute abdominal pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Mark I Neuman, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Richard M Ruddy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     George D Ferry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/61/22490/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/61/22490/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/61/22490/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among children, abdominal pain is a frequent, nonspecific symptom that is typically associated with self-limited, minor conditions such as gastroenteritis and other viral illnesses. The challenge for the clinician is to identify patients with abdominal pain who may have the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serious, potentially life-threatening conditions, such as appendicitis or bowel obstruction (as can occur from volvulus, intussusception, or adhesions)",
"     </li>",
"     <li>",
"      Infections that require specific treatment (such as streptococcal pharyngitis, urinary tract infection, or pneumonia)",
"     </li>",
"     <li>",
"      Unusual manifestations of less common diseases (such as Hirschsprung's disease or primary bacterial peritonitis with nephrotic syndrome)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In observational series describing children with abdominal pain evaluated in outpatient clinics or emergency departments, 22 percent had diagnoses that required surgery or treatment with antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Clinical experience suggests that in most outpatient settings, the proportion of children with serious conditions is even lower.",
"   </p>",
"   <p>",
"    Developmental considerations that must be recognized when evaluating infants and children with acute abdominal pain include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conditions that cause abdominal pain may occur more commonly at specific ages (such as volvulus among neonates and intussusception among older infants and toddlers).",
"     </li>",
"     <li>",
"      Infants and young children often cannot describe or localize their symptoms. In addition, they may be anxious about interactions in the healthcare setting, making identification of important physical findings challenging.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For most children, the etiology of abdominal pain can be identified with a careful history, either single or repeated physical examinations, and (in some cases) selective ancillary testing. Unavoidably, a small number of patients who may present early in the course of an illness (such as appendicitis) or with subtle",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atypical signs do not receive the definitive diagnosis on the first evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/2\">",
"     2",
"    </a>",
"    ]. Consequently, repeat examination and reliable follow-up are essential components of the evaluation and management of children with acute abdominal pain.",
"   </p>",
"   <p>",
"    The emergent evaluation of children with acute abdominal pain, including a brief description of life-threatening and common causes, will be discussed in this review. The evaluation and management of children with chronic abdominal pain is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/17/1306?source=see_link\">",
"     \"Evaluation of the child and adolescent with chronic abdominal pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6984?source=see_link\">",
"     \"Management of the child and adolescent with chronic abdominal pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of acute abdominal pain in children are summarized here (",
"    <a class=\"graphic graphic_table graphicRef65488 \" href=\"UTD.htm?28/20/29005\">",
"     table 1",
"    </a>",
"    ). A more detailed discussion can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link\">",
"     \"Causes of acute abdominal pain in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Life-threatening causes of abdominal pain may be associated with specific clinical features. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of acute abdominal pain in children and adolescents\", section on 'Life-threatening causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trauma - Intraabdominal injuries can be life-threatening (such as hemorrhage from solid organ laceration or fluid loss, organ ischemia from vascular injury, and infection from perforated hollow viscus). Typical mechanisms include motor vehicle crashes, falls, and child abuse.",
"     </li>",
"     <li>",
"      Obstruction and peritoneal irritation - These clinical features are associated with serious intraabdominal conditions that require prompt diagnosis and treatment. Conditions that cause obstruction",
"      <span class=\"nowrap\">",
"       and/",
"      </span>",
"      or peritonitis include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For neonates presenting with bilious vomiting, volvulus (as a complication of malrotation) and necrotizing enterocolitis should be considered.",
"     </li>",
"     <li>",
"      Intussusception (invagination of a part of the intestine into itself, causing obstruction) usually occurs among children two months to two years of age. Colicky abdominal pain is a typical feature of intussusception.",
"     </li>",
"     <li>",
"      Among children of all ages, appendicitis can cause peritoneal irritation and focal tenderness. It occurs most commonly in children &gt;5 years of age. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Obstruction as the result of adhesions from previous surgery or inflammation, complications of Hirschsprung disease, perforated ulcer, and primary bacterial peritonitis (usually as a complication of nephrotic syndrome) are uncommon causes of abdominal pain among children.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incarcerated inguinal hernia is an extraabdominal cause of abdominal pain that can be life-threatening. Myocarditis and pericarditis are rare extraabdominal causes of abdominal pain.",
"     </li>",
"     <li>",
"      Systemic life-threatening conditions that can be associated with abdominal pain include diabetic ketoacidosis and hemolytic uremic syndrome.",
"     </li>",
"     <li>",
"      Among postmenarchal females, life-threatening conditions within the reproductive tract that can cause abdominal pain include pelvic inflammatory disease with tubo-ovarian abscess and ruptured ectopic pregnancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Common conditions that are associated with acute abdominal pain include viral gastroenteritis, systemic viral illness, streptococcal pharyngitis, lobar pneumonia, and urinary tract infections. Frequent causes of chronic or recurrent abdominal pain include colic (among neonates) and constipation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H14#H14\">",
"     \"Causes of acute abdominal pain in children and adolescents\", section on 'Common causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of abdominal pain include gastrointestinal and nongastrointestinal conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H27#H27\">",
"     \"Causes of acute abdominal pain in children and adolescents\", section on 'Other causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrointestinal conditions that may present with abdominal pain include inflammatory bowel disease (more often Crohn disease than ulcerative colitis), cholecystitis (more common among children with predisposing conditions such as hemolytic anemia or cystic fibrosis or among older adolescents), pancreatitis, dietary protein allergy (typically in neonates and infants), malabsorption, and intraabdominal abscess (as from perforated appendicitis).",
"     </li>",
"     <li>",
"      Conditions outside of the gastrointestinal tract may cause abdominal pain. These include Henoch-Sch&ouml;nlein purpura (IgA vasculitis) (usually with a distinctive purpuric rash over the lower extremities and buttock), vasoocclusive crisis with sickle cell syndromes, ovarian torsion, testicular torsion, urolithiasis (typically with colicky pain and flank tenderness), some tumors, and toxic ingestions (such as lead or iron).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first goal of the evaluation of children with abdominal pain is to identify life-threatening conditions that require emergent interventions. Once this has been accomplished, other causes of abdominal pain can often be identified through deliberate evaluation with careful attention to the clinical features of the illness (such as the child's age and gender, history of trauma, pattern of the pain, related symptoms, physical findings, and selected diagnostic studies) (",
"    <a class=\"graphic graphic_algorithm graphicRef57204 \" href=\"UTD.htm?29/4/29764\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef69041 \" href=\"UTD.htm?1/2/1058\">",
"     algorithm 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key historical variables that may assist in identifying a specific cause of abdominal pain include history of trauma, prior abdominal surgery, fever, vomiting, location of the abdominal pain, and the pattern of symptoms. A gynecologic history (including last menstrual period and sexual activity) should be obtained for pubertal girls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal trauma (typically sustained in motor vehicle crashes, auto-pedestrian collisions, or falls) can cause life-threatening injuries (such as solid organ injury or perforated viscus). A history of trauma may not be forthcoming for infants and children who have sustained inflicted injuries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link&amp;anchor=H11#H11\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\", section on 'Abdominal injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although symptoms of abdominal injury typically occur immediately, they may be delayed with some injuries (such as left shoulder pain from a slowly expanding splenic hematoma, vomiting from obstruction as the result of a duodenal hematoma, or bowel perforation associated with a lap seatbelt injury). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of blunt abdominal trauma in children\", section on 'Specific injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Characteristics of abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants and children younger than two years of age with abdominal pain usually cannot describe or localize pain. This limitation leads to both over and under attribution of symptoms to &ldquo;abdominal pain.&rdquo; Parents may infer that the child has abdominal pain from symptoms such as drawing the legs up or inconsolability. The preschool child may be able to describe pain and other symptoms, although descriptions may not be consistently reliable. Above five years of age, children can typically characterize the onset, frequency, duration, and location of their symptoms.",
"   </p>",
"   <p>",
"    Specific diagnoses may be associated with the following characteristic patterns of pain:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Appendicitis &ndash; Periumbilical, migrating to the right lower abdomen",
"     </li>",
"     <li>",
"      Appendiceal rupture (early), ovarian torsion &ndash; Acute, severe, focal",
"     </li>",
"     <li>",
"      Intussusception &ndash; Intermittent, colicky",
"     </li>",
"     <li>",
"      Gastroenteritis &ndash; Diffuse or vague",
"     </li>",
"     <li>",
"      Hepatitis and cholecystitis &ndash; Right upper quadrant",
"     </li>",
"     <li>",
"      Gastritis, gastric ulcer disease &ndash; Epigastric",
"     </li>",
"     <li>",
"      Pancreatitis &ndash; Steady periumbilical pain, often radiating to the back",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For children with peritoneal irritation (as with advanced appendicitis), pain can be aggravated by movements that change tension on the abdominal wall (such as traveling in the car or walking). In comparison, patients with visceral pain may writhe with discomfort. Improvement in pain after a bout of emesis may occur with conditions localized to the small bowel [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/3\">",
"     3",
"    </a>",
"    ]. Pain relief after a bowel movement suggests a colonic condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Associated symptoms",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Fever",
"      </strong>",
"      &ndash; Children with abdominal pain frequently have fever. In an observational series describing children evaluated for abdominal pain in outpatient settings, 64 percent had a history of fever [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/2\">",
"       2",
"      </a>",
"      ]. Patients with appendicitis often have fever, which may be initially low grade. Most children with abdominal pain and fever, however, have infectious etiologies such as gastroenteritis, viral syndromes, and pharyngitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/1,2\">",
"       1,2",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Bacterial infections that may be associated with abdominal pain include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Streptococcal pharyngitis (often with sore throat, headache, and vomiting), although children with viral pharyngitis can also have abdominal pain (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H3#H3\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Bacteria'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Urinary tract infections (sometimes with vomiting or, less often, diarrhea in younger children) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lower lobe pneumonia (usually with respiratory symptoms such as tachypnea or cough, but without abdominal tenderness on examination) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/4\">",
"       4",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pelvic inflammatory disease (in postmenarchal, sexually active females) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vomiting",
"      </strong>",
"      &ndash; Vomiting is frequently reported among children with abdominal pain. In the previously noted series, 42 percent of patients had a history of vomiting [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/2\">",
"       2",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Children with vomiting and abdominal pain (particularly in the absence of diarrhea) should be carefully evaluated for life-threatening conditions such as bowel obstruction and appendicitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Volvulus must be excluded as the cause of bilious emesis and apparent abdominal pain in a neonate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link&amp;anchor=H8#H8\">",
"       \"Intestinal malrotation\", section on 'Volvulus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With intussusception, vomiting (initially non-bilious, but becoming bilious as the obstruction progresses) may occur following episodes of pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H9#H9\">",
"       \"Intussusception in children\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Small bowel obstruction may develop as the result of many conditions, including postoperative or postinflammatory adhesions. Worldwide, ascaris infection is a common cause of small bowel obstruction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=see_link&amp;anchor=H5#H5\">",
"       \"Ascariasis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nausea and vomiting are typically present among children with appendicitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H5#H5\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Diarrhea",
"      </strong>",
"      &ndash; The following conditions can be associated with diarrhea:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children with diarrhea and abdominal pain usually have viral gastroenteritis.",
"     </li>",
"     <li>",
"      Urinary tract infections can cause diarrhea.",
"     </li>",
"     <li>",
"      Diarrhea (typically mucoid stools, rather than profuse, watery diarrhea) may develop from appendicitis, usually with abscess formation.",
"     </li>",
"     <li>",
"      Children with intussusception may have bloody stools, sometimes mixed with mucus (currant jelly). In addition, intussusception may be preceded by viral gastroenteritis (particularly from adenovirus). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H9#H9\">",
"       \"Intussusception in children\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H3#H3\">",
"       \"Intussusception in children\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bloody diarrhea suggests infectious enteritis, hemolytic uremic syndrome (HUS), or inflammatory bowel disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other symptoms that may suggest the etiology of abdominal pain include cough (pneumonia), sore throat (pharyngitis), dysuria (urinary tract infection), polyuria (diabetic ketoacidosis), and hematuria (urinary tract infection, urolithiasis, hemolytic uremic syndrome, Henoch-Sch&ouml;nlein purpura [IgA vasculitis]).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Past medical history",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bowel obstruction from adhesions can occur among children who have had abdominal surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H9#H9\">",
"       \"Causes of acute abdominal pain in children and adolescents\", section on 'Adhesions with intestinal obstruction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with Hirschsprung disease can develop complications such as obstruction and fulminant enterocolitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34950?source=see_link&amp;anchor=H5#H5\">",
"       \"Emergency complications of Hirschsprung disease\", section on 'Enterocolitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cholecystitis may be the cause of abdominal pain for older adolescents or children with predisposing conditions such as sickle cell disease or cystic fibrosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=see_link&amp;anchor=H32#H32\">",
"       \"Overview of the clinical manifestations of sickle cell disease\", section on 'Hepatobiliary complications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=see_link&amp;anchor=H12#H12\">",
"       \"Cystic fibrosis: Clinical manifestations and diagnosis\", section on 'Biliary disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abdominal pain may be the manifestation of vasoocclusive crisis (VOC) for children with sickle cell disease. Other emergent conditions should be considered as suggested by specific findings (such as peritoneal signs or focal right lower quadrant pain), by a pattern of pain that is not typical of VOC for this patient, or for a child whose symptoms do not improve with hydration and analgesia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of the clinical manifestations of sickle cell disease\", section on 'Acute painful episodes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with diabetic ketoacidosis may have abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features and diagnosis of diabetic ketoacidosis in children\", section on 'Signs and symptoms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Primary bacterial peritonitis occurs with increased frequency among children with nephrotic syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25974?source=see_link&amp;anchor=H2#H2\">",
"       \"Complications of idiopathic nephrotic syndrome in children\", section on 'Infection'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive physical examination, including vital signs and detailed abdominal examination, is essential for the child with acute abdominal pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appearance and hydration should be noted. Patients with hypovolemia (as with abdominal injury, volvulus, or intussusception) or peritonitis (as from perforated appendicitis) may have signs of poor perfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link\">",
"     \"Assessment of perfusion in pediatric resuscitation\"",
"    </a>",
"    .) Children with peritonitis typically prefer to lie still, while those with biliary or renal colic may writhe in pain. Children with jaundice may have hepatitis or hemolysis. However, children with intussusception early in the course of their disease may appear quite well in between episodes of peristalsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal vital signs may provide a clue to the diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever suggests infection (such as gastroenteritis, urinary tract infection, pneumonia, or pharyngitis). Although many children with appendicitis are febrile, fever is neither sensitive nor specific for this condition [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tachypnea can be a sign of respiratory illness (such as pneumonia) or metabolic acidosis (causing rapid breathing in children with dehydration from gastroenteritis, diabetic ketoacidosis, peritonitis, or intestinal obstruction).",
"     </li>",
"     <li>",
"      Hypotension in a child with acute abdominal pain can develop from intravascular volume loss (as with hemorrhage from injury, gastroenteritis, or capillary leak from bowel obstruction with volvulus or intussusception) or peritonitis (as with perforated appendicitis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Abdominal examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The abdomen should be examined when the child is quiet and cooperative, in a position of comfort (such as a caretaker's lap), and before more anxiety provoking or uncomfortable parts of the examination (such as ears and throat). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38471?source=see_link&amp;anchor=H10#H10\">",
"     \"The pediatric physical examination: Chest and abdomen\", section on 'Abdomen'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following features should be noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Distention may be the result of obstruction or a mass.",
"     </li>",
"     <li>",
"      Bowel sounds may be decreased (as with an ileus in response to peritoneal irritation from appendicitis) or increased (as with gastroenteritis or bowel obstruction).",
"     </li>",
"     <li>",
"      Pain may be localized with gentle palpation performed in all four quadrants. Considerations include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children can be asked to point with one finger to the spot that hurts the most.",
"     </li>",
"     <li>",
"      Reproducible focal tenderness suggests an intraabdominal inflammatory process.",
"     </li>",
"     <li>",
"      Serious causes of abdominal pain are less likely for otherwise healthy children who are not uncomfortable with deep palpation throughout the abdomen, who have no focal tenderness, and who have no extraabdominal findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among older children, tenderness can sometimes be localized to the abdominal wall by demonstrating that tenderness to palpation is exacerbated when the child lifts her head off of the table.",
"     </li>",
"     <li>",
"      Percussive tenderness, rebound, and involuntary guarding are most often signs of peritoneal irritation (as with appendicitis or cholecystitis). Other findings that may be noted with percussion include increased tympany (as with distended bowel), dullness (as with a mass), and shifting dullness (as with ascites).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although rectal examination (to assess for local tenderness, mass, constipation, and hematochezia) is generally recommended as part of the evaluation for abdominal pain, it is uncomfortable. Observational evidence suggests that rectal examination may not be useful either for diagnosing appendicitis among children with abdominal pain or for identifying injuries among trauma patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/1,6-10\">",
"     1,6-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on rectal examination that should be noted include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hard stool in the rectal vault supports the diagnosis of constipation, but does not prove that this common condition is responsible for a given episode of acute abdominal pain.",
"     </li>",
"     <li>",
"      Blood in the stool can be seen in a variety of conditions, including intussusception, inflammatory bowel disease, dietary protein allergy, infectious enteritis, and constipation with anal fissure.",
"     </li>",
"     <li>",
"      Uterine or adnexal tenderness or masses (suggesting a gynecologic source for abdominal pain) may rarely be noted on rectal examination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     General examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extraabdominal findings on physical examination can provide important information regarding the cause of abdominal pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pharyngeal erythema",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exudate can be seen with pharyngitis.",
"     </li>",
"     <li>",
"      Rales, decreased breath sounds, or egophony on auscultation of the chest are suggestive of pneumonia.",
"     </li>",
"     <li>",
"      Muffled heart sounds or a rub may be seen with pericarditis, a gallop rhythm may occur in myocarditis, and tachycardia is typically a feature of both conditions.",
"     </li>",
"     <li>",
"      Flank tenderness may be a sign of pyelonephritis or urolithiasis.",
"     </li>",
"     <li>",
"      Tender scrotal swelling suggests testicular torsion or incarcerated hernia.",
"     </li>",
"     <li>",
"      Bruising suggests trauma. Petechiae",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      purpura may seen with Henoch-Sch&ouml;nlein purpura (IgA vasculitis).",
"     </li>",
"     <li>",
"      A characteristic rash occurs with scarlet fever or Henoch-Sch&ouml;nlein purpura (IgA vasculitis).",
"     </li>",
"     <li>",
"      Jaundice may be observed in children with hepatitis, gall bladder disease with obstruction, or hemolysis (as with sickle cell disease).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sexually active females with lower abdominal pain should generally receive bimanual pelvic examinations to look for signs of pelvic inflammatory disease, adnexal masses or cysts, uterine pathology, or ectopic pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=see_link\">",
"     \"The gynecologic history and pelvic examination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abdominal pain who are otherwise healthy, well-appearing, and have normal physical examinations typically do not require ancillary studies. Those whose repeat examinations continue to be unremarkable and who tolerate feeding can usually be discharged with reliable medical follow-up.",
"   </p>",
"   <p>",
"    Laboratory and radiographic studies should be performed when history",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical examination demonstrate focal findings or suggest concerning diagnoses (such as injury, appendicitis, bowel obstruction, or infection). The choice of tests should be based upon the age of the child and the diagnoses under consideration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific studies that may be considered include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      White blood cell count (WBC) &ndash; An elevated WBC suggests infection or inflammation (such as appendicitis), although a normal WBC does not exclude these processes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H1301606#H1301606\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Laboratory testing'",
"      </a>",
"      .) WBC &gt;20,000 suggests perforated appendicitis, appendiceal abscess, or lobar pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hematocrit &ndash; For children with bleeding, hematocrits that are initially normal establish baselines for serial measurements. Anemia with abnormal red cell morphology can be seen with hemoglobinopathies (sickling) and hemolytic uremic syndrome (microangiopathic changes). Children with hemolytic uremic syndrome also have thrombocytopenia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/55/35704?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\", section on 'Clinical and laboratory manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum chemistries &ndash; Among children with upper abdominal pain, abnormal liver enzyme tests or amylase measurements suggest hepatitis, cholecystitis, or pancreatitis. Metabolic acidosis can occur with dehydration, intestinal obstruction, peritonitis, or diabetic ketoacidosis (DKA). An elevated blood glucose in the setting of acidosis is also consistent with DKA.",
"     </li>",
"     <li>",
"      A urine dipstick evaluation (for blood, nitrites, leukocyte esterase, glucose, ketones, and protein) should be obtained for most children with abdominal pain. A formal urinalysis should be sent when the dipstick is abnormal. Hematuria can occur with urolithiasis, Henoch-Sch&ouml;nlein purpura (IgA vasculitis), hemolytic uremic syndrome, and urinary tract infection (UTI). Pyuria usually indicates a UTI, but a small number of WBCs (10 to 20",
"      <span class=\"nowrap\">",
"       WBCs/hpf)",
"      </span>",
"      can be seen with appendicitis (presumably when inflammation irritates the bladder wall). Children with DKA have glucosuria and ketonuria. A child with nephrotic syndrome and bacterial peritonitis typically has proteinuria.",
"     </li>",
"     <li>",
"      Urine pregnancy testing should generally be performed for postmenarchal females with abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H8967182#H8967182\">",
"       \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Urine pregnancy test'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rapid streptococcal antigen testing or bacterial throat culture &ndash; Children with abdominal pain and pharyngeal findings should usually receive rapid screening tests",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      throat cultures for group A beta hemolytic Streptococcus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H17#H17\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Identifying GAS pharyngitis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging is an essential component of the evaluation of some children with acute abdominal pain who have concerning clinical features such as trauma, peritoneal irritation, signs of obstruction, masses, distension, or focal tenderness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pain. Children with a typical clinical presentation for acute appendicitis are likely to have appendicitis. In this circumstance, we encourage clinicians to consult a surgeon with experience caring for children prior to obtaining imaging studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H6659006#H6659006\">",
"     \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain radiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abdominal films may demonstrate signs of obstruction (such as air fluid levels, distended bowel, or sentinel bowel loops) or perforation (such as free air) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56921 \" href=\"UTD.htm?32/7/32881\">",
"       image 1",
"      </a>",
"      ). Fluid-filled loops of small bowel can be seen with gastroenteritis. A fecalith in the right lower quadrant of a child with abdominal pain suggests the diagnosis of appendicitis. Children with acute abdominal pain due to constipation may have increased stool noted with abdominal radiography. The absence of at least moderate amounts of stool excludes this diagnosis as an explanation for acute abdominal pain.",
"     </li>",
"     <li>",
"      For children who may have midgut volvulus, an upper GI contrast series is the best examination to visualize the duodenum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77126 \" href=\"UTD.htm?18/59/19391\">",
"       image 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link&amp;anchor=H12#H12\">",
"       \"Intestinal malrotation\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although obstruction or mass effect may be seen on plain film, ultrasound is the best diagnostic test for intussusception. In addition, contrast enema (air or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      ) can diagnose and often reduce an intussusception (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54310 \" href=\"UTD.htm?30/43/31423\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53913 \" href=\"UTD.htm?41/52/42831\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65639 graphicRef75297 \" href=\"UTD.htm?28/25/29078\">",
"       image 5A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H15#H15\">",
"       \"Intussusception in children\", section on 'Nonoperative reduction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A chest radiograph may reveal basilar pneumonia or signs of myocarditis (cardiomegaly) as the cause of abdominal pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasonography (US)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      US is the preferred imaging modality to diagnose gall stones and genitourinary conditions (such as ovarian torsion, ruptured ovarian cyst, and testicular torsion).",
"     </li>",
"     <li>",
"      Intussusception can be diagnosed by experienced ultrasonographers (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68659 \" href=\"UTD.htm?21/16/21763\">",
"       image 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H11#H11\">",
"       \"Intussusception in children\", section on 'Ultrasonography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ultrasonographic findings that are suggestive of volvulus include abnormal position of the superior mesenteric vein, a \"whirlpool\" sign of volvulus (caused by the vessels twisting around the base of the mesenteric pedicle), and dilated duodenum (indicating duodenal obstruction by Ladd bands). A normal ultrasonogram does not exclude malrotation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link&amp;anchor=H16#H16\">",
"       \"Intestinal malrotation\", section on 'Ultrasonography'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The utility of US for diagnosing appendicitis depends upon the experience of the ultrasonographer, and may also vary based upon a child&rsquo;s body mass index. US can be highly sensitive and specific if the appendix is visualized (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52767 \" href=\"UTD.htm?19/50/20263\">",
"       image 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56139 \" href=\"UTD.htm?43/43/44735\">",
"       image 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef61146 \" href=\"UTD.htm?2/5/2139\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=see_link&amp;anchor=H4189074#H4189074\">",
"       \"Acute appendicitis in children: Diagnostic imaging\", section on 'Diagnostic approach'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=see_link&amp;anchor=H4189194#H4189194\">",
"       \"Acute appendicitis in children: Diagnostic imaging\", section on 'Test performance'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Focused abdominal sonography for trauma (FAST examination), typically performed in the emergency department, can detect free fluid (usually blood) in the abdomen. For a hypotensive trauma victim, a negative FAST examination by an experienced ultrasonographer generally excludes massive intraabdominal hemorrhage as the explanation for shock. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\", section on 'Ultrasound'",
"      </a>",
"      .) Experience with this modality in children is limited [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/13-15\">",
"       13-15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Computed tomography (CT) with contrast is useful for the evaluation of patients with acute abdominal pain when a wide variety of diagnoses are being considered (such as appendicitis, pancreatitis, intraabdominal abscess, and for the evaluation of an intraabdominal mass). The sensitivity and specificity of CT for diagnosing appendicitis are &gt;90 percent and 85 to 90 percent, respectively. The test characteristics for CT scan for the diagnosis of appendicitis in children vary based on the use and type of contrast (IV, oral, rectal, or a combination thereof) administered. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=see_link&amp;anchor=H9#H9\">",
"       \"Acute appendicitis in children: Diagnostic imaging\", section on 'Computed tomography (CT)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ultrasound and non-contrasted helical CT are potential imaging modalities for patients with acute colicky pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hematuria and suspected urolithiasis. Ultrasound has limited sensitivity but is preferred by some experts as an initial test, especially in young children. Helical CT is the most sensitive imaging test for renal or ureteral stones in children. Low dose protocols may provide adequate resolution for identifying most calculi or alternative diagnoses, with significant reduction in radiation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13623?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical features and diagnosis of nephrolithiasis in children\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ANALGESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that children with acute abdominal pain receive effective analgesia, as indicated by their degree of discomfort.",
"   </p>",
"   <p>",
"    The practice of providing analgesia to patients undergoing evaluation for acute abdominal pain has been controversial. Classic teaching is that opiates can alter examination findings, potentially complicating the diagnostic process. Furthermore, several survey studies have suggested that substantial practice variation exists with regard to the use and timing of analgesia in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three clinical trials have concluded that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    analgesia in children with acute abdominal pain provides significant pain reduction without affecting the examination or the ability to identify those with surgical conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Nevertheless, observational data indicate that the majority of children evaluated in the emergency department for abdominal pain may not receive adequate analgesia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with acute abdominal pain who have conditions that require emergent diagnosis and treatment can be effectively identified with a systematic approach that considers age, the presence of worrisome clinical features, and selected ancillary studies (",
"    <a class=\"graphic graphic_table graphicRef65488 \" href=\"UTD.htm?28/20/29005\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef57204 \" href=\"UTD.htm?29/4/29764\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef69041 \" href=\"UTD.htm?1/2/1058\">",
"     algorithm 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in the evaluation of abdominal pain in children is to identify those who have sustained trauma. For this population, injury is the likely cause of abdominal pain and a specific approach to the evaluation is required. Mechanisms typically associated with significant injury (such as solid organ laceration or perforated viscus) include motor vehicle crashes, motor vehicle pedestrian collisions, falls, and physical assault (including child abuse). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link&amp;anchor=H11#H11\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\", section on 'Abdominal injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rapid, aggressive stabilization and evaluation are indicated for children with the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unstable vital signs at presentation",
"     </li>",
"     <li>",
"      Obvious serious or multiple injuries",
"     </li>",
"     <li>",
"      High risk mechanism of injury (penetrating injury, severe blunt trauma, fall from higher than 20 feet, ejection from a vehicle, impact velocity more than 30 miles per hour)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Identification of specific injuries, when clinically indicated, typically requires imaging:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Focused abdominal sonography for trauma (FAST examination) may detect free fluid (usually blood) in the abdomen. Experience with this modality in children is limited. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\", section on 'Ultrasound'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Solid organ injuries are generally diagnosed with abdominal computed tomography, whereas plain radiographs may demonstrate signs of a perforated viscus (although normal plain radiography does not exclude perforation).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Signs of obstruction or peritoneal irritation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs of obstruction (such as abdominal distention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bilious vomiting), history of prior abdominal surgery (predisposing to adhesions which may cause obstruction), and peritoneal irritation (such as guarding, percussive tenderness, and rebound) are clinical features associated with serious intraabdominal conditions that require prompt diagnosis and treatment.",
"   </p>",
"   <p>",
"    In every case where clinical findings suggest obstruction or peritonitis, either treatment must be initiated (such as laparotomy for suspected appendicitis) or diagnostic steps must be undertaken to identify a cause. Supportive care (such as monitoring, intravenous isotonic crystalloid fluids, analgesia, and often parenteral antibiotics) should be provided while results from ancillary studies are pending. Hospital admission for observation and serial examinations should occur for any patient with signs of obstruction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peritoneal irritation for whom a cause cannot be identified.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Obstruction",
"      </strong>",
"      &ndash; Life-threatening causes of abdominal pain as the result of bowel obstruction include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Volvulus (most often in neonates). An upper GI contrast series is the imaging study of choice. Ultrasonography may demonstrate findings suggestive of malrotation, but a normal study does not exclude the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link&amp;anchor=H12#H12\">",
"       \"Intestinal malrotation\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intussusception (usually two months to two years of age). Plain radiographs of the abdomen are commonly normal, but may show frank intestinal obstruction, a mass effect from an intussusceptum, or distended loops of bowel with absence of colonic gas. The diagnosis may be confirmed with ultrasound performed by an experienced ultrasonographer. Contrast enema (air or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      ) can diagnose and often reduce an intussusception. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H10#H10\">",
"       \"Intussusception in children\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H15#H15\">",
"       \"Intussusception in children\", section on 'Nonoperative reduction'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Peritoneal irritation",
"      </strong>",
"      &ndash; The following conditions should be considered in children with abdominal pain and signs of peritoneal irritation:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Necrotizing enterocolitis (NEC) occurs rarely among term neonates who have been discharged from nurseries. Such infants typically have preexisting illnesses associated with poor mesenteric perfusion (such as congenital heart disease) or have hypoperfusion such as from protracted diarrhea. Abdominal radiography may demonstrate signs of ileus or characteristic findings such as pneumatosis intestinalis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78676 \" href=\"UTD.htm?15/9/15508\">",
"       image 9",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link&amp;anchor=H6#H6\">",
"       \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Appendicitis occurs more often among children over five years of age, but can also be the cause of abdominal pain and peritoneal irritation in infants and younger children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H5#H5\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rarely, an ingested foreign body may become lodged within the GI tract, causing tissue damage or bowel perforation. The vast majority of foreign bodies (even sharp ones) that progress beyond the gastroesophageal junction pass uneventfully through the gastrointestinal tract and out with the stool, requiring no intervention. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15337?source=see_link&amp;anchor=H11#H11\">",
"       \"Button and cylindrical battery ingestion\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=see_link\">",
"       \"Foreign bodies of the esophagus and gastrointestinal tract in children\"",
"      </a>",
"      .) Case reports have described volvulus following the ingestion of small magnets. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H25#H25\">",
"       \"Causes of acute abdominal pain in children and adolescents\", section on 'Foreign body ingestion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with idiopathic nephrotic syndrome who have poorly controlled disease and ascites may develop spontaneous bacterial peritonitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25974?source=see_link&amp;anchor=H3#H3\">",
"       \"Complications of idiopathic nephrotic syndrome in children\", section on 'Bacterial infection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cholecystitis and pancreatitis are unusual causes of abdominal pain among children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"      </a>",
"      .) Children with cholecystitis are usually &gt;5 years of age and often have predisposing conditions such as hemoglobinopathies or cystic fibrosis. Causes of pancreatitis among children include trauma, infection, structural anomalies, and some medications (such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/38/28262?source=see_link\">",
"       tetracycline",
"      </a>",
"      , L-asparaginase, valproic acid, and steroids) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Meckel's diverticulum may cause abdominal pain mimicking an acute abdomen, but is more typically associated with painless rectal bleeding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29513?source=see_link&amp;anchor=H19#H19\">",
"       \"Diagnostic approach to lower gastrointestinal bleeding in children\", section on 'Meckel's diverticulum'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Perforation of a peptic ulcer is an unusual cause of abdominal pain and peritoneal irritation among children, particularly those &lt;10 years of age. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13609?source=see_link&amp;anchor=H6#H6\">",
"       \"Clinical manifestations of peptic ulcer disease\", section on 'Ulcer complications'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Focal physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with no apparent injuries and no evidence of obstruction or obvious peritonitis may have serious intraabdominal conditions such as intussusception or appendicitis. At this point, however, the likelihood of serious disease is lower, allowing for a more deliberate evaluation. This should include a search for extraabdominal conditions that may cause abdominal pain and abdominal findings (such as a mass or focal tenderness) that suggest an intraabdominal process, neither of which may be obvious, particularly in a young, frightened, or uncooperative child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Extraabdominal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abdominal pain require a full physical examination, looking for signs of systemic illness and for disease in areas adjacent to the abdomen. Specific attention should be focused on the vital signs, the skin, pharynx, the chest, the heart, and the genital region. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Physical examination'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Henoch-Sch&ouml;nlein purpura (HSP [IgA vasculitis (IgAV)]) often causes abdominal pain (",
"      <a class=\"graphic graphic_table graphicRef60175 \" href=\"UTD.htm?24/8/24716\">",
"       table 3",
"      </a>",
"      ). Patients generally have a typical ecchymotic rash over the lower extremities and buttocks (",
"      <a class=\"graphic graphic_picture graphicRef63367 graphicRef72094 \" href=\"UTD.htm?26/46/27367\">",
"       picture 1A-B",
"      </a>",
"      ). Pain may develop before the rash in some cases. Intussusception may rarely develop as a complication of HSP (IgAV). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with streptococcal pharyngitis often have abdominal pain, in addition to pharyngeal irritation and exudate, although those with viral pharyngitis may also have abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H4#H4\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Group A streptococcus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lower lobe pneumonia or pleural effusion may cause diaphragmatic irritation and abdominal pain. Usually, children will have fever and abnormal findings on chest examination (such as tachypnea, nasal flaring, rales,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dullness to percussion).",
"     </li>",
"     <li>",
"      Myocarditis and pericarditis may present with abdominal pain. It may be the result of poor cardiac output with mesenteric insufficiency or secondary to distension of the liver from heart failure. The pain usually manifests in the right upper quadrant and is accompanied by a tender liver edge on abdominal palpation.",
"     </li>",
"     <li>",
"      Children with testicular torsion or incarcerated inguinal hernias may complain of abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link&amp;anchor=H2#H2\">",
"       \"Causes of scrotal pain in children and adolescents\", section on 'Testicular torsion'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21561?source=see_link\">",
"       \"Overview of inguinal hernia in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful palpation of the abdomen may identify an abdominal mass, suggesting the following diagnoses:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A mass in the right abdomen suggests intussusception, although most children with intussusception do not have this finding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H9#H9\">",
"       \"Intussusception in children\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignant solid tumors are rare causes of abdominal pain in previously healthy children. Pain typically develops with bleeding into the tumors. More often, tumors present as painless masses. Wilms' tumor and neuroblastoma occur more commonly in infants, whereas leukemic or lymphomatous involvement of the liver, spleen, or retroperitoneal lymph nodes occurs more often in older children. Other causes include hepatic tumors, ovarian tumors, soft tissue sarcomas, and vascular malformations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/47/5882?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical assessment of the child with suspected cancer\", section on 'Abdominal masses'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with intraabdominal abscesses are typically febrile and may have had previous abdominal surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38905?source=see_link&amp;anchor=H17#H17\">",
"       \"Etiologies of fever of unknown origin in children\", section on 'Intraabdominal abscess'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Constipation can cause abdominal pain with an abdominal mass. Associated clinical features include prior episodes of constipation, hard stool in the rectal vault, large amounts of stool on abdominal radiographs, and absence of other concerning signs or symptoms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15354?source=see_link\">",
"       \"Constipation in children: Etiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Focal tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal tenderness on physical examination must be identified whenever possible, because this finding may be the only indication of serious intraabdominal pathology. Localized tenderness on physical examination may indicate the following causes for abdominal pain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Right lower quadrant abdominal tenderness suggests appendicitis, although children without focal tenderness may on occasion also have appendicitis, particularly early in the course of disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H5#H5\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ovarian torsion can cause localized lower abdominal tenderness that may be indistinguishable from appendicitis when the right ovary is involved. It may occasionally occur without producing focal tenderness. Patients are typically nauseous, as with appendicitis. Although it commonly occurs as the result of an ovarian cyst, ovarian torsion can develop in a normal ovary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link&amp;anchor=H327710#H327710\">",
"       \"Ovarian and fallopian tube torsion\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cholecystitis and pancreatitis can cause right upper quadrant and epigastric or periumbilical tenderness, respectively. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urolithiasis may cause severe colicky flank pain which radiates into the lower abdomen. On palpation there is tenderness in the flank and lower abdomen. Pyelonephritis may cause flank tenderness with fever",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dysuria.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Colicky pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intussusception should be considered for all children two months to two years of age with diffuse, colicky, severe abdominal pain and for those with predisposing conditions (such as Henoch-Sch&ouml;nlein purpura (IgA vasculitis) and Peutz-Jeghers syndrome) regardless of findings on physical examination (including overall appearance and the presence or absence of blood in the stool).",
"   </p>",
"   <p>",
"    Imaging studies that can confirm the diagnosis include contrast enema and ultrasound. Contrast enema, usually air, should be obtained initially for patients in whom there is a high index of suspicion for intussusception because this study may be diagnostic and therapeutic. Abdominal plain radiographs and ultrasound may be useful when the diagnosis is uncertain (as is often the case), provided that these studies do not significantly delay the definitive diagnosis and treatment of intussusception. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H10#H10\">",
"     \"Intussusception in children\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link&amp;anchor=H15#H15\">",
"     \"Intussusception in children\", section on 'Nonoperative reduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Nonspecific symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abdominal pain who have not been injured and have no signs of obstruction, peritoneal irritation, evidence of extraabdominal diseases, focal findings, or a pattern of pain suggestive of intussusception typically have infections, systemic illnesses, or a variety of minor problems (such as constipation).",
"   </p>",
"   <p>",
"    For children with severe nonspecific abdominal pain, the following diagnoses, even without other distinguishing features, are possible:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intussusception (age two months to two years, intermittent pattern)",
"     </li>",
"     <li>",
"      Ovarian torsion or ruptured ovarian cyst (female)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infections that may present with abdominal pain include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Viral or bacterial gastroenteritis (usually with diarrhea) and systemic viral syndromes (such as influenza).",
"     </li>",
"     <li>",
"      Pneumonia and pharyngitis (to a lesser extent) can occasionally cause abdominal pain with a paucity of findings in the chest or pharynx, respectively.",
"     </li>",
"     <li>",
"      Intraabdominal abscess (as from a ruptured appendix) may cause fever and abdominal pain without focal tenderness, particularly in a young child.",
"     </li>",
"     <li>",
"      Children with hepatitis may be anicteric early in their course.",
"     </li>",
"     <li>",
"      Young children with urinary tract infections may not have dysuria, particularly if they have pyelonephritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abdominal pain can be a nonspecific feature of a number of conditions that typically have other distinguishing clinical or laboratory features. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetic ketoacidosis (Kussmaul respirations, fruity breath, polyuria, glucosuria, ketonuria)",
"     </li>",
"     <li>",
"      Hemolytic uremic syndrome (pallor, petechiae, microangiopathic anemia, thrombocytopenia, renal failure)",
"     </li>",
"     <li>",
"      Henoch-Sch&ouml;nlein purpura (IgA vasculitis) (",
"      <a class=\"graphic graphic_table graphicRef60175 \" href=\"UTD.htm?24/8/24716\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pancreatitis (elevated amylase and lipase levels)",
"     </li>",
"     <li>",
"      Urolithiasis (hematuria)",
"     </li>",
"     <li>",
"      Iron intoxication (occult blood in stool, foreign body on abdominal plain radiography) (",
"      <a class=\"graphic graphic_table graphicRef61711 \" href=\"UTD.htm?8/44/8909\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hepatitis (jaundice, hyperbilirubinemia)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with chronic or recurrent abdominal pain must always be evaluated carefully for other causes, particularly when the pattern is not typical or symptoms do not respond to the usual treatment. As an example, a child with sickle cell disease and abdominal pain who does not improve with hydration and analgesia as expected in patients with vasoocclusive crisis may have appendicitis or gall bladder disease. An approach to children with chronic abdominal pain is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/17/1306?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation of the child and adolescent with chronic abdominal pain\", section on 'Differential diagnosis'",
"    </a>",
"    .) Conditions to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among neonates, colic is a diagnosis of exclusion that can often be distinguished from other causes of prolonged crying with a careful history and physical examination (",
"      <a class=\"graphic graphic_table graphicRef79185 \" href=\"UTD.htm?0/27/445\">",
"       table 5",
"      </a>",
"      ). In young infants for whom the diagnosis is uncertain, a one to two hour period of observation in which no symptoms are observed provides support for the diagnosis of colic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/52/15177?source=see_link&amp;anchor=H2#H2\">",
"       \"Evaluation and management of colic\", section on 'Clinical evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with dietary protein allergy may develop irritability that is interpreted as abdominal pain. They typically pass blood-tinged stools and mucus, but do not have diarrhea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link&amp;anchor=H2#H2\">",
"       \"Food protein-induced proctitis/colitis and enteropathy of infancy\", section on 'Food protein-induced proctitis/proctocolitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with conditions that cause malabsorption (such as celiac disease and carbohydrate malabsorption) may have recurrent abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical manifestations and diagnosis of celiac disease in children\", section on 'Gastrointestinal symptoms'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/17/1306?source=see_link&amp;anchor=H10#H10\">",
"       \"Evaluation of the child and adolescent with chronic abdominal pain\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abdominal pain may be a typical manifestation of vasoocclusive crises for children with sickle cell syndromes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of the clinical manifestations of sickle cell disease\", section on 'Acute painful episodes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link\">",
"       \"Variant sickle cell syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intermittent abdominal pain is a classic but now rare feature of lead poisoning. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=see_link&amp;anchor=H6#H6\">",
"       \"Childhood lead poisoning: Clinical manifestations and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory bowel disease (more often Crohn disease than ulcerative colitis) may present with intermittent abdominal pain. Associated features may include diarrhea, hematochezia, and weight loss. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical manifestations of Crohn's disease in children and adolescents\", section on 'Overview'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=see_link&amp;anchor=H2#H2\">",
"       \"Treatment of ulcerative colitis in children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Constipation and functional abdominal pain are diagnoses of exclusion for children with recurrent abdominal pain without other concerning features. An abdominal radiograph to confirm the presence of at least moderate amounts of stool, although often performed, does not correlate well with the diagnosis of constipation and is not a routine part of evaluation of children not previously diagnosed with constipation who present with acute pain, particularly in the emergency department [",
"      <a class=\"abstract\" href=\"UTD.htm?21/61/22490/abstract/26\">",
"       26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/17/1306?source=see_link&amp;anchor=H10#H10\">",
"       \"Evaluation of the child and adolescent with chronic abdominal pain\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Adolescent females",
"    </span>",
"    &nbsp;&mdash;&nbsp;For adolescent girls, an algorithmic approach must include diagnoses related to reproductive organ development and function (",
"    <a class=\"graphic graphic_algorithm graphicRef69041 \" href=\"UTD.htm?1/2/1058\">",
"     algorithm 2",
"    </a>",
"    ). Urine pregnancy testing should generally be performed for postmenarchal females with abdominal pain, whether or not sexual activity is reported.",
"   </p>",
"   <p>",
"    Visual inspection may detect imperforate hymen in adolescent females with abdominal pain, abdominal mass, and primary amenorrhea in association with advanced sexual maturation (Tanner stage IV or V). An imperforate hymen is the simplest defect that results in primary amenorrhea and is typically associated with cyclic pelvic pain and a perirectal mass from sequestration of blood in the vagina (hematocolpos). Similar findings can be seen with defects in perineal development, which can result in absence of the distal third of the vagina and therefore absence of an outflow tract. Both of these conditions are diagnosed by physical examination. An imperforate hymen is easily corrected with surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the conditions discussed above, the following should also be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Additional diagnoses to consider for postmenarchal sexually active girls with abdominal pain who have signs of peritoneal irritation with no history of trauma include pelvic inflammatory disease (PID) and ruptured ectopic pregnancy. A bimanual pelvic examination may identify cervical motion tenderness or an adnexal mass. Pelvic ultrasonography is the imaging modality typically used to identify tuboovarian abscess and ectopic pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For a postmenarchal female with no history of trauma and no peritoneal signs, an abdominal mass may represent an intrauterine pregnancy or hydrometrocolpos in a patient with imperforate hymen. Ovarian torsion or a ruptured ovarian cyst typically causes focal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link&amp;anchor=H327710#H327710\">",
"       \"Ovarian and fallopian tube torsion\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pregnancy (intrauterine or ectopic) must be considered as a cause of abdominal pain in postmenarchal females, whether or not sexual activity is reported. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/31/10744?source=see_link&amp;anchor=H3#H3\">",
"       \"Pregnancy in adolescents\", section on 'Diagnosis of pregnancy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dysmenorrhea may be the cause of recurrent abdominal pain that develops during menses. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31125?source=see_link\">",
"       \"Primary dysmenorrhea in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/48/8962?source=see_link\">",
"       \"Patient information: Acute abdomen (belly pain) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For most children, the causes of abdominal pain are self-limited, minor conditions such as gastroenteritis, constipation, and other viral illnesses. Children who have experienced trauma or who have signs of bowel obstruction (such as abdominal distention",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bilious vomiting) or peritoneal irritation (such as guarding, percussive tenderness, and rebound) may have serious conditions that require prompt diagnosis and treatment (",
"      <a class=\"graphic graphic_table graphicRef65488 \" href=\"UTD.htm?28/20/29005\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link\">",
"       \"Causes of acute abdominal pain in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A systematic approach to the emergent evaluation of the child with acute abdominal pain that considers the patient's age and the presence of specific signs and symptoms, as well as selected ancillary studies, generally identifies those who have conditions that require emergent diagnosis and treatment. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children with acute abdominal pain should receive effective analgesia, as indicated by their degree of discomfort, while they are being evaluated for a cause (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Algorithmic approaches to the evaluation of children (",
"      <a class=\"graphic graphic_algorithm graphicRef57204 \" href=\"UTD.htm?29/4/29764\">",
"       algorithm 1",
"      </a>",
"      ) and postmenarchal girls (",
"      <a class=\"graphic graphic_algorithm graphicRef69041 \" href=\"UTD.htm?1/2/1058\">",
"       algorithm 2",
"      </a>",
"      ) with acute abdominal pain are suggested. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Algorithmic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unavoidably, some patients with acute abdominal pain may not receive the definitive diagnosis on the first evaluation because they present early in the course (such as appendicitis) or with subtle",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      atypical signs. Repeat examination and reliable follow-up to evaluate evolving clinical features are therefore essential components of the evaluation and management of children with acute abdominal pain.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/1\">",
"      Reynolds SL, Jaffe DM. Diagnosing abdominal pain in a pediatric emergency department. Pediatr Emerg Care 1992; 8:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/2\">",
"      Scholer SJ, Pituch K, Orr DP, Dittus RS. Clinical outcomes of children with acute abdominal pain. Pediatrics 1996; 98:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/3\">",
"      Leung AK, Sigalet DL. Acute abdominal pain in children. Am Fam Physician 2003; 67:2321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/4\">",
"      Ravichandran D, Burge DM. Pneumonia presenting with acute abdominal pain in children. Br J Surg 1996; 83:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/5\">",
"      Bundy DG, Byerley JS, Liles EA, et al. Does this child have appendicitis? JAMA 2007; 298:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/6\">",
"      Dickson AP, MacKinlay GA. Rectal examination and acute appendicitis. Arch Dis Child 1985; 60:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/7\">",
"      Andersson RE, Hugander AP, Ghazi SH, et al. Why does the clinical diagnosis fail in suspected appendicitis? Eur J Surg 2000; 166:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/8\">",
"      Shlamovitz GZ, Mower WR, Bergman J, et al. Poor test characteristics for the digital rectal examination in trauma patients. Ann Emerg Med 2007; 50:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/9\">",
"      Shlamovitz GZ, Mower WR, Bergman J, et al. Lack of evidence to support routine digital rectal examination in pediatric trauma patients. Pediatr Emerg Care 2007; 23:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/10\">",
"      Kristinsson G, Wall SP, Crain EF. The digital rectal examination in pediatric trauma: a pilot study. J Emerg Med 2007; 32:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/11\">",
"      Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999; 33:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/12\">",
"      Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med 2007; 14:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/13\">",
"      Soundappan SV, Holland AJ, Cass DT, Lam A. Diagnostic accuracy of surgeon-performed focused abdominal sonography (FAST) in blunt paediatric trauma. Injury 2005; 36:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/14\">",
"      Suthers SE, Albrecht R, Foley D, et al. Surgeon-directed ultrasound for trauma is a predictor of intra-abdominal injury in children. Am Surg 2004; 70:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/15\">",
"      Holmes JF, Brant WE, Bond WF, et al. Emergency department ultrasonography in the evaluation of hypotensive and normotensive children with blunt abdominal trauma. J Pediatr Surg 2001; 36:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/16\">",
"      Nissman SA, Kaplan LJ, Mann BD. Critically reappraising the literature-driven practice of analgesia administration for acute abdominal pain in the emergency room prior to surgical evaluation. Am J Surg 2003; 185:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/17\">",
"      Wolfe JM, Lein DY, Lenkoski K, Smithline HA. Analgesic administration to patients with an acute abdomen: a survey of emergency medicine physicians. Am J Emerg Med 2000; 18:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/18\">",
"      Tait IS, Ionescu MV, Cuschieri A. Do patients with acute abdominal pain wait unduly long for analgesia? J R Coll Surg Edinb 1999; 44:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/19\">",
"      Kim MK, Strait RT, Sato TT, Hennes HM. A randomized clinical trial of analgesia in children with acute abdominal pain. Acad Emerg Med 2002; 9:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/20\">",
"      Green R, Bulloch B, Kabani A, et al. Early analgesia for children with acute abdominal pain. Pediatrics 2005; 116:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/21\">",
"      Bailey B, Bergeron S, Gravel J, et al. Efficacy and impact of intravenous morphine before surgical consultation in children with right lower quadrant pain suggestive of appendicitis: a randomized controlled trial. Ann Emerg Med 2007; 50:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/22\">",
"      Kim MK, Galustyan S, Sato TT, et al. Analgesia for children with acute abdominal pain: a survey of pediatric emergency physicians and pediatric surgeons. Pediatrics 2003; 112:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/23\">",
"      Goldman RD, Crum D, Bromberg R, et al. Analgesia administration for acute abdominal pain in the pediatric emergency department. Pediatr Emerg Care 2006; 22:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/24\">",
"      Kandula L, Lowe ME. Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 2008; 152:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/25\">",
"      Werlin SL, Kugathasan S, Frautschy BC. Pancreatitis in children. J Pediatr Gastroenterol Nutr 2003; 37:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/61/22490/abstract/26\">",
"      Reuchlin-Vroklage LM, Bierma-Zeinstra S, Benninga MA, Berger MY. Diagnostic value of abdominal radiography in constipated children: a systematic review. Arch Pediatr Adolesc Med 2005; 159:671.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6434 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-125.39.66.147-DB4EA05A22-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22490=[""].join("\n");
var outline_f21_61_22490=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Characteristics of abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Associated symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Past medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Appearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Vital signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Abdominal examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - General examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ANALGESIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Signs of obstruction or peritoneal irritation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Focal physical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Extraabdominal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Mass",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Focal tenderness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Colicky pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Nonspecific symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Adolescent females",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6434\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6434|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?29/4/29764\" title=\"algorithm 1\">",
"      Algorithm - acute abdominal pain boys and premenarchal girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?1/2/1058\" title=\"algorithm 2\">",
"      Algorithm - acute abdominal pain postmenarchal girls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6434|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/7/32881\" title=\"diagnostic image 1\">",
"      Intussusception with small bowel obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/59/19391\" title=\"diagnostic image 2\">",
"      UGI duodenal bulb",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/43/31423\" title=\"diagnostic image 3\">",
"      Intussusception Barium enema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/52/42831\" title=\"diagnostic image 4\">",
"      Intussusception Air contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/58/27552\" title=\"diagnostic image 5A\">",
"      Intussusception Air contrast II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/10/5282\" title=\"diagnostic image 5B\">",
"      Intussusception Air contrast III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/16/21763\" title=\"diagnostic image 6\">",
"      Intussusception Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/50/20263\" title=\"diagnostic image 7\">",
"      Ultrasound of appendicitis child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/43/44735\" title=\"diagnostic image 8\">",
"      Appendicitis ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/9/15508\" title=\"diagnostic image 9\">",
"      Plain radiographs - necrotizing enterocolitis in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6434|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/32/33282\" title=\"picture 1A\">",
"      Rash - Henoch Schonlein purpura IgA vasculitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/46/42721\" title=\"picture 1B\">",
"      Rash - Henoch Schonlein purpura IgA vasculitis B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6434|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/20/29005\" title=\"table 1\">",
"      Acute abdominal pain in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/5/2139\" title=\"table 2\">",
"      Sonographic signs appendicitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/8/24716\" title=\"table 3\">",
"      Findings - Henoch Schoelein purpura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/44/8909\" title=\"table 4\">",
"      Acute iron intoxication - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/27/445\" title=\"table 5\">",
"      Differential diagnosis of prolonged crying",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=related_link\">",
"      Acute appendicitis in children: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=related_link\">",
"      Acute appendicitis in children: Diagnostic imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=related_link\">",
"      Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=related_link\">",
"      Ascariasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=related_link\">",
"      Assessment of perfusion in pediatric resuscitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15337?source=related_link\">",
"      Button and cylindrical battery ingestion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=related_link\">",
"      Causes of acute abdominal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=related_link\">",
"      Causes of scrotal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=related_link\">",
"      Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/47/5882?source=related_link\">",
"      Clinical assessment of the child with suspected cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13623?source=related_link\">",
"      Clinical features and diagnosis of nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=related_link\">",
"      Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/55/35704?source=related_link\">",
"      Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=related_link\">",
"      Clinical manifestations and diagnosis of celiac disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=related_link\">",
"      Clinical manifestations of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13609?source=related_link\">",
"      Clinical manifestations of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25974?source=related_link\">",
"      Complications of idiopathic nephrotic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15354?source=related_link\">",
"      Constipation in children: Etiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29513?source=related_link\">",
"      Diagnostic approach to lower gastrointestinal bleeding in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34950?source=related_link\">",
"      Emergency complications of Hirschsprung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38905?source=related_link\">",
"      Etiologies of fever of unknown origin in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/52/15177?source=related_link\">",
"      Evaluation and management of colic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/17/1306?source=related_link\">",
"      Evaluation of the child and adolescent with chronic abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=related_link\">",
"      Foreign bodies of the esophagus and gastrointestinal tract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=related_link\">",
"      Intestinal malrotation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=related_link\">",
"      Intussusception in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6984?source=related_link\">",
"      Management of the child and adolescent with chronic abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=related_link\">",
"      Ovarian and fallopian tube torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21561?source=related_link\">",
"      Overview of inguinal hernia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=related_link\">",
"      Overview of the clinical manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/48/8962?source=related_link\">",
"      Patient information: Acute abdomen (belly pain) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/31/10744?source=related_link\">",
"      Pregnancy in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31125?source=related_link\">",
"      Primary dysmenorrhea in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=related_link\">",
"      The gynecologic history and pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38471?source=related_link\">",
"      The pediatric physical examination: Chest and abdomen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=related_link\">",
"      Treatment of ulcerative colitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=related_link\">",
"      Variant sickle cell syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_61_22491="Organ function change age";
var content_f21_61_22491=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Age-related organ function changes relevant to colorectal cancer treatment",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organ system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age-related change",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential CRC relevance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone Marrow",
"       </td>",
"       <td>",
"        &darr; Cellularity and reserve",
"       </td>",
"       <td>",
"        &uarr; Risk of leukopenia: dose reduction and growth factor often needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver",
"       </td>",
"       <td>",
"        &darr; Parenchymal volume",
"       </td>",
"       <td>",
"        Less able to tolerate oxaliplatin steatohepatitis, metastasectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kidney",
"       </td>",
"       <td>",
"        &darr; Glomerular filtration rate",
"       </td>",
"       <td>",
"        &uarr; Risk of prerenal azotemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiovascular",
"       </td>",
"       <td>",
"        &uarr; CAD, valvular disease, HTN",
"       </td>",
"       <td>",
"        <p>",
"         Fluoropyrimidine coronary vasospasm",
"        </p>",
"        <p>",
"         Greater risk from bevacizumab-related hypertension and arterial thromboembolism",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central nervous system",
"       </td>",
"       <td>",
"        <p>",
"         &darr; Cerebral perfusion",
"        </p>",
"        <p>",
"         &uarr; Autonomic disturbance",
"        </p>",
"       </td>",
"       <td>",
"        5-FU-associated cerebellar toxicity, with greater effect on balance, gait",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22491=[""].join("\n");
var outline_f21_61_22491=null;
var title_f21_61_22492="Treatment of Pneumocystis infection";
var content_f21_61_22492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs used in the treatment of Pneumocystis pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dosage",
"      </td>",
"      <td class=\"subtitle1\">",
"       Major adverse reactions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Preferred regimen",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       TMP-SMX",
"      </td>",
"      <td>",
"       Not acutely ill (able to take oral medication; PaO2&gt;70 mm Hg): Two double strength TMP-SMX tabs orally every 8 hours",
"      </td>",
"      <td rowspan=\"2\">",
"       Rash, fever, neutropenia, hyperkalemia, transaminase elevation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Acutely ill (not able to take oral medicaion; PaO2&lt;70 mm Hg): TMP-SMX (15 mg/kg of TMP component per day) intravenously divided every 6 to 8 hours",
"       </p>",
"       <p>",
"        PLUS",
"       </p>",
"       <p>",
"        Prednisone* taper:",
"       </p>",
"       <p>",
"        40 mg PO twice daily for 5 days",
"       </p>",
"       <p>",
"        40 mg PO once daily for 5 days",
"       </p>",
"       <p>",
"        20 mg PO once daily for 11 days",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Alternative regimens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pentamidine",
"      </td>",
"      <td>",
"       4 mg/kg/day IV once daily",
"      </td>",
"      <td>",
"       Nephrotoxicity, hyperkalemia, hypoglycemia, hypotension, pancreatitis, dysrhythmias, transaminase elevation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Atovaquone",
"      </td>",
"      <td>",
"       750 mg PO twice daily",
"      </td>",
"      <td>",
"       Rash, fever, transaminase elevation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       TMP plus dapsone",
"      </td>",
"      <td>",
"       <p>",
"        TMP: 5 mg/kg PO three times daily",
"       </p>",
"       <p>",
"        Dapsone: 100 mg/day PO once daily",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Trimethoprim: Rash, gastrointestinal distress, transaminase elevation, neutropenia",
"       </p>",
"       <p>",
"        Dapsone: Rash, fever, gastrointestinal upset, methemoglobinemia, hemolytic anemia, (check for G6PD deficiency)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Primaquine plus clindamycin",
"      </td>",
"      <td>",
"       <p>",
"        Primaquine: 15-30 mg/day PO once daily",
"       </p>",
"       <p>",
"        Clindamycin: 600 mg IV every 8 hours",
"        <strong>",
"         OR",
"        </strong>",
"        300-450 mg PO four times daily",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Primaquine: Rash, fever, methemoglobinemia, hemolytic anemia (check for G6PD deficiency)",
"       </p>",
"       <p>",
"        Clindamycin: Rash, diarrhea, Clostridium difficile colitis, abdominal pain",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients should receive 21 days of therapy.",
"    <div class=\"footnotes\">",
"     TMP-SMX: Trimethoprim-sulfamethoxazole.",
"     <br>",
"      * Adjunctive glucocorticoids should be given to patients with a room air PA02 &lt;/=70 mmHg or alveolar-arterial oxygen gradient &gt;/=35 mmHg.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22492=[""].join("\n");
var outline_f21_61_22492=null;
var title_f21_61_22493="Incidence of AF with age";
var content_f21_61_22493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Increasing incidence of AF with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 266px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Incidence of atrial fibrillation according to age in almost 4000 male air crew recruits followed continuously for 44 years in the Manitoba Follow-up Study.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Krahn AD, Manfreda J, Tate RB, et al. Am J Med 1995; 98:476.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22493=[""].join("\n");
var outline_f21_61_22493=null;
var title_f21_61_22494="CRC incidence Natl Polyp Study";
var content_f21_61_22494=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Observed and expected colorectal cancer incidence in national polyp study cohort after colonoscopic polypectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 292px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Winawer, SJ, Zauber, AG, Ho, MN, et al, N Engl J Med 1993; 329:1977.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22494=[""].join("\n");
var outline_f21_61_22494=null;
var title_f21_61_22495="Conduit leak A";
var content_f21_61_22495=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leaking conduit at urethral anastomosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 281px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiograph showing conduit leak at urethral anastomosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_61_22495=[""].join("\n");
var outline_f21_61_22495=null;
